TWI357442B - Risk prediction for hypertension, elevated plasma - Google Patents

Risk prediction for hypertension, elevated plasma Download PDF

Info

Publication number
TWI357442B
TWI357442B TW94134166A TW94134166A TWI357442B TW I357442 B TWI357442 B TW I357442B TW 94134166 A TW94134166 A TW 94134166A TW 94134166 A TW94134166 A TW 94134166A TW I357442 B TWI357442 B TW I357442B
Authority
TW
Taiwan
Prior art keywords
gene
lpl
hypertension
genes
risk
Prior art date
Application number
TW94134166A
Other languages
Chinese (zh)
Inventor
Wen Harn Pan
Yuh Shan Jou
Jaw Wen Chen
Cathy S J Fann
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Priority to TW94134166A priority Critical patent/TWI357442B/en
Application granted granted Critical
Publication of TWI357442B publication Critical patent/TWI357442B/en

Links

Description

1357442 九、發明說明: 【發明所屬之技術領域】 *本發明係關於高血壓、三酸甘油脂偏高及代謝症候群 的遺傳風險因子’及其相關組成份及應用。 【先前技術】 问血壓為心血管疾病的主要風險因子,且為一嚴重的全球大 眾健f問^。世界上約有將近十億人口為此症所苦(Mein CA, 2^04) °由家庭及流行病學研究的證據指出高血壓源自於遺傳及環 ^因子,複雜的交互作用(HaiTap SB,Chapter24 in ref)2。雙胞胎研 究及分離分析顯示2〇%-40%的血壓(BP)變化歸因於遺傳因子 (Wai^R,1990)3。針對幾個孟德爾式高血壓性狀及高血壓實驗模 型,咼血壓基因的遺傳定位已有重大進展(MeinCA,2〇〇4)。然而, 此人類複雜性狀的常見遺傳變異尚未被闡明(Mein CA,2〇〇4)ι。 於患有家族性混合型高脂血症(FCHL)及家族性高三酸甘油脂 症(FHTG)之病人的研究中顯示,與正常族群相比,高血壓較常出 現於該族群中(Hopkins PN et al.,2003)4。此外,三酸甘油脂(TG) 與血壓相關,且高血壓病人患高三酸甘油脂症的情況通常超 出預期’,7。這些聚集的現象(clusteringphen〇men〇n)最近被視為代 謝症候群(MS)的一部分,其特徵為一群組疾病,包含高身體質量 指數(BMI)或是大腰圍、三酸甘油脂偏高、高密度脂蛋白膽固醇 (HDL-C)偏低、高血壓、及葡萄糖耐受不良(GM,#公极j 1996)8。多種證據已顯示代謝症候群在心血管疾病的形成上扮演重 要的角色(Grundy SM et al,2004)9。 脂蛋白脂分解酶(LPL)為一參與代謝「富含三酸甘油脂粒子」 (TG-rich particles)成游離脂肪酸並將其釋放至循環中的關鍵酵1357442 IX. Description of the invention: [Technical field to which the invention pertains] * The present invention relates to a high risk of hypertension, a high triglyceride and a genetic risk factor of metabolic syndrome and related components and applications thereof. [Prior Art] Asking blood pressure is the main risk factor for cardiovascular disease, and it is a serious global public health. Nearly one billion people in the world suffer from this disease (Mein CA, 2^04) ° Evidence from family and epidemiological studies indicates that hypertension is derived from genetic and cyclic factors, complex interactions (HaiTap SB , Chapter24 in ref) 2. Twin studies and separation analysis showed that 2〇%-40% of blood pressure (BP) changes were attributed to genetic factors (Wai^R, 1990)3. For several Mendelian hypertension traits and hypertension experimental models, the genetic localization of sputum blood pressure genes has made significant progress (MeinCA, 2〇〇4). However, the common genetic variation of this human complex trait has not yet been elucidated (Mein CA, 2〇〇4) ι. In studies of patients with familial mixed hyperlipidemia (FCHL) and familial triglyceride (FHTG), hypertension is more common in the population than in the normal population (Hopkins PN) Et al., 2003) 4. In addition, triglycerides (TG) are associated with blood pressure, and hypertriglyceridemia in hypertensive patients usually exceeds expectations. These clustering phenomena (clusteringphen〇men〇n) have recently been considered as part of the metabolic syndrome (MS) and are characterized by a group of diseases, including high body mass index (BMI) or high waist circumference and high triglycerides. High-density lipoprotein cholesterol (HDL-C), high blood pressure, and glucose intolerance (GM, #公极j 1996)8. A variety of evidence has shown that metabolic syndrome plays an important role in the development of cardiovascular disease (Grundy SM et al, 2004). Lipoprotein lipolytic enzyme (LPL) is a key leaven that participates in the metabolism of "TG-rich particles" into free fatty acids and releases them into the circulation.

1357442 I 素。έ豆據顯示,具酵素活性缺陷的雜合子,相較於野生型, 傾向具有南濃度空腹TG及高血壓(Sprecher DL et al,1996) i〇(WilliamS RR et al.,1994)11。此外,LPL的活性異常與胰島素阻 抗性、肥胖、糖尿病血脂異常、乳糜微粒血(chyl〇micr〇naemia)、 動脈粥狀硬化及心絞痛等具有相關性(Mead爪过吐2〇〇2) 12(Goodarzi MO, 2004)13 (Kastelein John JP et al,2000)m。因此,我 們將ZPZ納入高血壓基因定位計畫中許多候選者之一。在我們之 剞的報告中(Pan et al.,2000)15,利用受影響兄弟姊姝配對方法 (affected sib-pair method )’我們於台灣中華漢族早發性高血壓族 群中發現相關標記(D8S1145, p = 0.0284)有正向訊號。收縮壓 的定量性狀基因座及LPL附近之遺傳標記的關聯,亦被記載於台 灣的糖尿病家族(Wu,et al.,1996)i6。雖然在高加索人的研究中, 基因型與血壓的相關性有所爭議(Hunt et al,1999; Clee SM, 2001)17’18,最近的獨立研究顯示中國大陸漢民族之χ凡多型性及 高血壓的正相關及關聯性,並進一步支持£凡於高血壓病源學中 所扮演的角色(Yang WJ,2003; Ma YQ,2002)19,20。因此,搜尋關於 上述病症有效的風險預測基因標記及治療方法是必須的。 【發明内容】 為了對高血壓及相關疾病定位單套基因及了解遺傳 變異於此複雜性狀各種面向的影響,我們針對早發性高血壓族群 進行LPZ區域之咼解析度定位,結果顯示兩個常見的尤凡單套基 因型,與高血壓、三酸甘油之偏高及/或代謝症候群(MS)有關。土 第一個單套基因(C/AA/T單套基因^於丄凡基因之内含子3至 内含子4區域含有二個單一核苷酸多型性(snps) : rs343⑼CBI基 因庫中NT一030737號之第7621708位置)、rs252(NCBI基因庫中 NT—030737號之第7622153位置)及rs253(NCBI基因庫中 1357442 ,ΝΤ_030737號之第7622338位置)。於此風險單套基因,位於這三 個位置的核苦酸分別為C、AA及T。其與二酸甘油脂(TG)偏南 (p=0.005)及高金壓結合三酸甘油脂(TG)偏ifj(p<0.0001)具有顯著 的相關性。 第二個單套基因(GTAG單套基因)於基因之内含子5至内 含子6區域含有四個SNPs : AF050163-2500 (NCBI基因庫中 NT_030737 號之第 7624101 位置)、rs269 (NCBI 基因庫中 NT_030737 號之第 7624588 位置)、rs270 (NCBI 基因庫中 NT—030737號之第7624597位置)和rs271 (NCBI基因庫中 B NT_030737號之第7624623位置)。會增高風險的單套基因型,位 於這四個位置的核苷酸分別為G、T、A及G。該單套基因型GTAG 與高血壓結合三酸甘油脂(TG)偏高病症(ρ<〇.〇〇〇ι)具有顯著的相 關性。 此外’攜帶以上兩種風險單套基因的人在罹患高血壓(丨5)、 三酸甘油脂偏高(1.9)、高血壓結合三酸甘油脂偏高(23)及代謝症候 群(1.8)上’具有最高、最明顯的危險對比值。1357442 I. Kidney Bean has been shown to have a heterozygous activity-deficient heterozygote that tends to have a southern concentration of fasting TG and hypertension compared to wild-type (Sprecher DL et al, 1996) i〇 (William S RR et al., 1994)11. In addition, LPL activity abnormalities are associated with insulin resistance, obesity, diabetic dyslipidemia, chyl〇micr〇naemia, atherosclerosis, and angina pectoris (Mead Paw Exfoliation 2〇〇2) 12 ( Goodarzi MO, 2004) 13 (Kastelein John JP et al, 2000) m. Therefore, we have included ZPZ as one of many candidates in the Hypertension Gene Location Program. In our report (Pan et al., 2000), using the affected sib-pair method, we found markers in the early-onset hypertension population of Chinese Han Chinese in Taiwan (D8S1145). , p = 0.0284) There is a positive signal. The association of quantitative traits of systolic blood pressure with genetic markers near LPL is also documented in the diabetes family in Taiwan (Wu, et al., 1996) i6. Although the association between genotype and blood pressure has been controversial in Caucasian studies (Hunt et al, 1999; Clee SM, 2001) 17'18, recent independent studies have shown that Chinese Han nationality is more versatile and The positive correlation and association of hypertension, and further support the role of the role in the etiology of hypertension (Yang WJ, 2003; Ma YQ, 2002)19,20. Therefore, it is necessary to search for risk predictor gene markers and treatments that are effective for the above conditions. SUMMARY OF THE INVENTION In order to locate a single set of genes for hypertension and related diseases and to understand the effects of genetic variation on various aspects of this complex trait, we mapped the resolution of the LPZ region for early-onset hypertension, and the results showed two common The Yufan single genotype is associated with hypertension, high triglycerides, and/or metabolic syndrome (MS). The first single set of genes in the soil (C/AA/T single set of genes) contains two single nucleotide polymorphisms (snps) in the intron 3 to intron 4 region of the 丄fan gene: rs343(9) CBI gene pool NT-030737, position 7621708), rs252 (NC762 gene bank, NT-030737, position 7622153) and rs253 (1357442 in the NCBI gene bank, position 7622338 of ΝΤ_030737). For this risk single set of genes, the nucleotide acids in these three positions are C, AA and T, respectively. It has a significant correlation with diamylglycerol (TG) south (p = 0.005) and high gold pressure combined triglyceride (TG) bias ifj (p < 0.0001). The second single set of genes (GTAG single set of genes) contains four SNPs in the intron 5 to intron 6 region of the gene: AF050163-2500 (position 7624101 of NT_030737 in the NCBI gene bank), rs269 (NCBI gene) In the library, the number 7624588 of NT_030737), rs270 (the position of 7624597 of NT-030737 in the NCBI gene bank) and rs271 (the position of 7624462 of B NT_030737 in the NCBI gene bank). A single set of genotypes that would increase risk, the nucleotides at these four positions are G, T, A, and G, respectively. This single genotype of GTAG has a significant correlation with hypertensive combined triglyceride (TG) high disease (ρ<〇.〇〇〇ι). In addition, 'the person carrying the above two risk single sets of genes is suffering from high blood pressure (丨5), high triglyceride (1.9), hypertension combined with high triglyceride (23) and metabolic syndrome (1.8). 'The highest and most obvious hazard comparison value.

一因此,本發明的-個方向提供了利用抓作為針對高血壓、 三酸甘油脂㈣、倾症候群及其他湖疾病 型^例而言,抓基因序列或是蛋白質序列可被用來評 =二二Ϊ甘油脂偏高、代謝症候群及其他相關疾病及醫學病 。特別的是橫跨内含子3至内含子4或 = = 使用,如C/鑛*單套= t除了值基因,其他與任何有關高血廢、 古 代謝症候群或其他糊疾錢醫學病症之说 ’〗呵、 標蝴帽。因此,這些其他的土因 被用來評估這些疾病及f學症狀的風險。1 β遺傳“)亦可 本發明亦可提供以奶作為針對高♦三酸甘油脂偏高、 7 1357442 I 代謝症候群及其相關疾病和症狀治療、量測、發展的目標。舉例 而言,及變異可被用於試管内及活體分析,以篩選可和 lpz及其變異結合、抑制LPL活性或恢復LPL活性之藥物。具有 • 活,的藥物’可進-步被分析,以決其用於治療或預防高 • 血壓、三酸甘油脂偏高、代謝症候群及其相關疾病和醫學症狀的 功用。特別適用於包含C/AA/T及/或GTAG單套基因型的LpL尚 異。 艾 一 *本發明亦提供包含突變或多型性的核酸,其與高血壓、 φ二酸甘油脂偏高、代謝症候群或其相關疾病或醫學症狀相關。本 f明亦提供具突變或多型性的蛋白質或胜肽,尤其能提供辨識變· 二蛋白質或胜肽的抗體,但非野生型脂蛋白脂分解酶蛋白質。包 含核,及互補賊喊體及宿主細胞亦被提供。尤其,可用於债 /貝J與四血壓、二酸甘油脂偏高、代謝症候群或相 痄 ^目關之说突變或多型性㈣子或探針亦被提供。進 的疋包含任何上述内容及使用指示的套組。 【實施方式】 姐基因與高血壓、三酸甘油祕高及代謝症料相關。位於 3至内含子4區域的-單套基聊/aa/t單套基因}及_ 上6區域的一單套基因(gtag單套基因),能預測 ―绝二4子病症的個人風險。此外,與任一單套基因 平衡的其他標記亦具__。本發明可被翻 亞洲族群、S加索人、祕顧人及其他_。 狀其他 护前,用於此應用 除非另外被指出,在進一步敘述本發明細節 的術έ吾定義如下。 1357442 定義 LPL與尚血壓、三酸甘触偏高及铺症候群有關 且亡與㊉三酸甘油脂為兩個代謝症狀中的主成分,並可能 •^二^二㈤此’说’—主要脂質代謝基因’被我們選為早 發性面企壓⑽™)家族冑灰壓基因的候選者之一。 严募59個核心ΥΗΤΝ家族,以25對兄弟姊妹對她⑽_ 仃初始連鎖分析研究 接下來用345個族族狀384個親子三 ^組(trios)執仃-相關確認實驗。我們藉由下列步驟檢測了奶盥 馬血壓及相關表現型的關係:以微衛星標 ^ J因中之聊、連鎖不平衡分析、單套基因型建構及以 的相關性分析(實施例1_5)。 ⑽基因中的微衛星標記與YHTN聯結。不平衡傳遞測試顯 不位於内含=3_4 # C/AA/T單套基_與三酸甘油脂㈣偏高 (P=0.00?及高血壓結合三酸甘油脂偏高兩種病症㈣細·著 相關。單套基因型GTAG與高Α壓及三酸甘油脂偏高同時存在的 表型(pO.OOOl)顯著相關。此外’帶有此二風險單套基因型的人具 有最,的高血壓(1.5)、三酸甘油脂偏高(1.9)、高血壓結合三酸甘二 脂偏高(2.3)及代謝症候群(1.8)危險對比值。 一,們的結果指出,二種常見的單套基因與高血壓、丁〇偏 咼、尚血壓結合TG偏高及代謝症候群相關。我們使用衛星標圮的 初始連鎖分析及使用L凡中SNP標記所做的單套基因型確認相關 研究,強烈支持的直接參與。於帶有兩個B(C/AA/T)及 D(GTAG)兩個風險單套基因型的病人’四個代謝症候群的風險最 強,且有這兩個單套基因型的人比例不低。 1357442 所有,的風險單套基_為常見的變異,分職 =早套基關2臟m 1們由Claric et al 加索人及非裔美國人的資料中理出’於88個單套基因中ϊ %個BmΒ的風險單套基因。關於Bin D,在相同研 = 單套基賴於88個單套基时佔12個。因此^ =早套基因型謂財國人巾常見,也f級高加纽非= ^到約概訊_獻。崎帶單纽錄因彳謝 症候群平均相對風險約為不帶單套風險基因型者的Μ倍 險百分比可被估計為15%_p⑽33。其顯示;台= 壓^中’ 15%的代謝症候群相_大可歸因為兩個J =PL早套基因型,因此,我們針對常見複雜狀,高血壓 代謝症候群,可說已辨識出一常見的遺傳變異。 謝广itr個自紐生的LPL突變,已被描述於多種類脂質代 謝疾病备中’但這些大多數為稀少的突變,包括61個錯意突變、 12個無意義突變、1〇個框架轉移突變或小型插入/刪除、3個非定 點突變(gross mutation)、8個拼接突變(splidng __及4個啟 動子變異(Merkel M et al. 細,繼)35。在其中,超過观 的這些突變都位於LPL之外鮮4、5及6輯,也就是服B、 C和D被辨識的區域。根據Tilbeurgh H van,汊以(1"句36,LpL 蛋白質具有兩個個別的區域:N端範圍(氨基酸,由外顯子 1-6編碼)’其負責酵素催化,及c端範圍(氨基酸313_448,由外 顯子7-9編碼),其與脂蛋白質基質結合丨^^心R,2〇〇2)12。此二範 圍相應至兩個Z/2:之不平衡聯結區塊,其被一位於内含子6,近外 員子6内各子6之父界的i.9kb之重組熱點(hotspots)隔開 (Templeton AR et a丨,2000)37。因此,胞B及灿〇的瓜變異分 別位於内含子3·4及内含子5_6,其耕與LpL的表現功能有關。 1357442 於啟動子區域(測試的571bp近端)及LPL基因之外顯子並沒有發 現變異’除了 一位於外顯子8的SNP及一位於外顯子的9的Ser44X7 雖然外顯子8-9的保護性單套基因型具有低於期望的傳遞現 像,足以影響二酸甘油脂偏高及高血壓患者的後代,其相關程度 並不似内含子5-6來的強(由傳遞不平衡測試決定),且其並不與= 血壓風險及其他代謝症候群相關表現型相關(資料未顯示)。° 一般認為,位於一内顯子區域内的多型性,可能是與一位在 編碼區或内含子·外顯子交界的功能性突變不平衡聯結而發生作 用。然而,我們所辨識的此二風險單套基因型並不在任何美 因之外顯突變之不平衡聯結内。為了解這些内含的變異σΑΑ/τ(ς ,外顯子4)及GTAG(跨越外顯子6)如何發揮功用,需要進一步的 试驗。至少有六項剪接體(splic_mal)内含子的不同功用被提 出’包括(1)非編瑪的RNA來源;(2)轉錄調控元件的媒介;⑶選 擇性及反式剪接法(trans_splidngW執行者;(4)編碼序列減數互換 (meiotic crossing)的促進者;(5)外顯子混洗的基質;及⑹福a由 核及,意義調控衰變的輸出訊號(Fed〇聰L咖Fed〇r〇v a 2003)38。 , 瓜單套基因型與局血壓和代謝症候群之相關性可被已知學 ,解,:代謝症候群與肥胖與騰島素阻抗性_,高血糖、高血 么油月日症及少董兩密度脂蛋白膽固醇為代謝症候群的 。軸這些代謝越群的各方面餘如何彼此相關,尚 練雜、脂毒性及肥胖卿起_島性阻抗 代謝症候群的致病路徑或發生順序可能為多 二、’們的發現支持含變異可能與三酸甘油脂於 液,、組織内的累積有關,而其可能導致高血壓、高三酸甘油脂 =代謝^群。文獻記載了 LPL的許多其他功用,例如,增加 、,施吸收月曰蛋白質的橋接功能、一單核細胞黏接蛋白質、促進血 1] ⑧ 1357442 V 管平滑肌肉細胞的增生,包括腫瘤纖維α因子基因的表現、刺激 确酸氧化物合成酶的表現、活化菸鹼醯胺腺嘌呤雙核苷酸/於鹼醯 胺腺嗓呤二核酸磷酸(ΝΑΕ^ΘΗ)氧化酶且減低脫辅基脂蛋白(Αρ〇 Ε)的分泌(Mead et al,2002)12,這些機制中的許多機制亦可促成高 血壓的生成。 總而言之’本發明提供一可預測病人患高血壓、三酸甘油脂 偏高或代謝症候群的遺傳風險的方法,包括篩檢病人的基 因。單套基因型C/AA/T或單套基因型GTAG或兩者的出現,為 籲代謝症候群相關病症的風險指標。基因序列可用任何已建立 於該技術領域的方法調查,例如使用與單套基因核酸序列特異黏鲁 合的寡聚核苷酸。聚合酵素鏈鎖反應(PCR)、聚合酶連鎖反應結合 單股構型多態性分析(PCR-SSCP)、變性梯度凝膠電泳(DGGE)及核 酿酶A錯位截斷方法’是現有方法的幾個例子。 值得注意的是’除了這邊所提到的單套基因及SNPs,與任一 ,異單套基因及SNPs連結的遺傳標記,也可被用來預測風險。這 疋因為靠近這些目標單套基因和SNPs的遺傳標記會與目標單套 ,因和SNPs —起被分離或產生不平衡聯結。因此,這些標記(同 φ 等遺傳標記)的出現,標示了目標單套基因及SNPs的出現,此即 表示了向血壓、二酸甘油脂偏高及/或代謝症候群的風險。同等遺籲 .傳標記可為任何標記,包括微衛星及SNPs標記。較佳地,有效的 遺傳標記來自ZPZ基因,其約為或小於200kb。更佳地標記為 來自 LPL 基因,其大小約為 i〇〇kb、80kb、60kb、40kb、20kb:Therefore, the present invention provides a use of grasping as a target for hypertension, triglyceride (four), sciatic syndrome, and other lake diseases. The capture gene sequence or protein sequence can be used to evaluate = two. High levels of diglyceride, metabolic syndrome and other related diseases and medical conditions. Especially across introns 3 to introns 4 or = = use, such as C/mine* single set = t in addition to value genes, others with any high blood waste, archabolic syndrome or other dysentery money medical illness Said '〗 〖, marked the butterfly cap. Therefore, these other soil factors are used to assess the risk of these diseases and symptoms. 1 β inheritance “) The present invention may also provide milk as a target for the treatment, measurement and development of high ♦ triglyceride, 7 1357442 I metabolic syndrome and related diseases and symptoms. For example, Variants can be used in in vitro and in vivo assays to screen for drugs that bind to lpz and its variants, inhibit LPL activity, or restore LPL activity. Drugs with • can be analyzed step by step to determine Treatment or prevention of high blood pressure, high levels of triglycerides, metabolic syndrome and related diseases and medical symptoms. Particularly suitable for LpL containing C/AA/T and/or GTAG single genotypes. * The present invention also provides a nucleic acid comprising a mutation or a polymorphism, which is associated with hypertension, φ diglyceride, metabolic syndrome or a related disease or medical condition. The present invention also provides mutation or polymorphism. Proteins or peptides, in particular, can provide antibodies that recognize variants of two proteins or peptides, but non-wild-type lipoprotein lipolytic enzyme proteins. Containing nuclei, and complementary thieves and host cells are also provided. In particular, they can be used for debt. /Bei J and four blood pressure, high diglyceride, metabolic syndrome or related to the mutation or polymorphism (four) or probe is also provided. The 疋 contains any of the above and the instructions for use [Embodiment] The sister gene is associated with hypertension, triglyceride secret and metabolic syndrome. It is located in the 3 to intron 4 region - single set of base chat / aa / t single set of genes} and _ upper 6 regions A single set of genes (gtag single set of genes) can predict the individual risk of a "single 4" disease. In addition, other markers that are balanced with any single set of genes also have __. The present invention can be turned over to Asian ethnic groups, S Gasolians, cautious persons, and others. For other applications, unless otherwise noted, the details of the details of the present invention are defined as follows. 1357442 Defining LPL with blood pressure and trisodium citrate High and stagnation syndrome related to death and triglyceride is the main component of two metabolic symptoms, and may be ^^^^(5) This 'speak'--the main lipid metabolism gene' was selected as an early-onset face One of the candidates for the (10)TM) family of sputum gray-pressed genes. Strictly raised 59 cores The ΥΗΤΝ family, with 25 pairs of brothers and sisters to her (10) _ initial chain analysis study, followed by 345 ethnic 384 parental trios (trios) stub-related confirmation experiments. We tested the milk scorpion by the following steps Relationship between blood pressure and related phenotypes: microsatellite markers, linkage disequilibrium analysis, single genotype construction, and correlation analysis (Example 1_5). (10) Microsatellite markers and YHTN in genes Coupling. Unbalanced transmission test is not located in the inclusion = 3_4 # C / A / T single set of base _ with triglyceride (four) is high (P = 0.00? and high blood pressure combined with triglyceride high two diseases (four) The correlation between the single genotype GTAG and the high sputum and triglyceride high phenotype (pO.O00l) was significantly correlated. In addition, people with this two risk single genotype have the highest hypertension (1.5), high triglyceride (1.9), high blood pressure combined with high acid triglyceride (2.3) and metabolic syndrome ( 1.8) Hazard comparison value. First, our results indicate that the two common single sets of genes are associated with hypertension, sputum sputum, high blood pressure combined with TG, and metabolic syndrome. We used the initial linkage analysis of satellite markers and the identification of related studies using a single set of genotypes using L-SNP markers, with strong support for direct participation. In patients with two B (C/AA/T) and D (GTAG) risk single genotypes, 'four metabolic syndromes are the most at risk, and the proportion of these two single genotypes is not low. . 1357442 All, the risk of a single set of base _ is a common variation, the division = early sets of base 2 dirty m 1 by Claric et al. Gasol and African American data from the '88 sets of genes Lieutenant % BmΒ risk single set of genes. Regarding Bin D, in the same research = 12 sets of bases rely on 88 single sets of bases. Therefore ^ = early genotypes are common in the country of the country, but also f-class high-plus New Zealand = ^ to about the news _ offer. The average relative risk of the syndrome is about 15%_p(10)33. The average relative risk of the syndrome is about 15% _p(10)33. It shows that the stage = 15% of the metabolic syndrome phase _ can be attributed to two J = PL early genotypes, therefore, we have identified a common occurrence for common complexities, hypertensive metabolic syndrome Genetic variation. Xie Guangitr's LPL mutation from Newton has been described in a variety of lipid-like metabolic diseases, but most of these are rare mutations, including 61 missense mutations, 12 nonsense mutations, and 1 frame transfer. Mutation or mini-insertion/deletion, 3 non-spot mutations, 8 splicing mutations (splidng __ and 4 promoter variants (Merkel M et al.), in which 35 The mutations are located in the fresh 4, 5, and 6 series outside the LPL, that is, the areas where B, C, and D are recognized. According to Tilbeurgh H van, (1", 36, LpL protein has two distinct regions: N The end range (amino acids, encoded by exons 1-6) 'is responsible for enzyme catalysis, and the c-terminal range (amino acids 313_448, encoded by exons 7-9), which binds to the lipoprotein matrix 丨^^^, 2〇〇2)12. These two ranges correspond to two Z/2: unbalanced junction blocks, which are located in the intron 6, the i.9kb of the parent of each child 6 in the near-outer member 6. The recombination hotspots are separated (Templeton AR et al, 2000) 37. Therefore, the melon B and the candied melon variation are located in intron 3, respectively. · 4 and intron 5_6, its ploughing is related to the performance function of LpL. 1357442 No mutation was found in the promoter region (the proximal 571 bp tested) and the LPL gene except for a SNP located in exon 8. And a Ser44X7 located in exon 9 Although the protective single genotype of exon 8-9 has a lower than expected delivery profile, which is sufficient to affect the high diglyceride and progeny of hypertensive patients, the degree of correlation Not as strong as intron 5-6 (determined by transmission imbalance test), and it is not related to = blood pressure risk and other metabolic syndrome-related phenotypes (data not shown). ° Generally considered to be located within one The polymorphism in the region of the exon may be linked to an imbalance of functional mutations at the junction of the coding region or the intron/exon. However, we identified this two-risk single genotype. It is not within the imbalance of mutations outside of any cause. To understand how these intrinsic variations σΑΑ/τ(ς, exon 4) and GTAG (cross exon 6) work, further testing is needed. At least six splices (splic_ma l) The different functions of introns are proposed 'including (1) non-coded RNA sources; (2) vectors for transcriptional regulatory elements; (3) selective and trans-splicing methods (trans_splidngW performers; (4) coding sequences minus The promoter of the meiotic crossing; (5) the matrix of the exon-mixing; and (6) the output signal of the nucleus and the regulation of the decay (Fed L 咖 咖 咖 咖 咖 咖 2003 〇 2003 2003). The correlation between the genotype of melon and the local blood pressure and metabolic syndrome can be known, solution, metabolic syndrome and obesity and the resistance of Tengdaosu _, hyperglycemia, hyperemia, oily day, and less Dong Density lipoprotein cholesterol is a metabolic syndrome. The various aspects of the metabolism of these axes are related to each other, and the pathogenesis or order of occurrence of dysfunction, lipotoxicity and obesity may be more than two. Triglycerides are involved in the accumulation of fluids and tissues, which may lead to hypertension, high triglycerides = metabolism. The literature documents many other functions of LPL, such as increasing, bridging the function of glutinous proteins, a monocyte-binding protein, and promoting the proliferation of smooth muscle cells, including tumor fiber alpha factor Gene expression, stimulation of acid oxide synthase expression, activation of nicotine guanamine adenine dinucleotide / alkali guanamine adenine dinucleotide phosphate (ΝΑΕ^ΘΗ) oxidase and reduction of apoprotein The secretion of Αρ〇Ε) (Mead et al, 2002) 12, many of these mechanisms can also contribute to the formation of hypertension. In general, the present invention provides a method for predicting a patient's genetic risk of hypertension, high triglycerides or metabolic syndrome, including screening for a patient's gene. The emergence of a single genotype of C/AA/T or a single genotype of GTAG or both is a risk indicator for metabolic syndrome-related conditions. The gene sequence can be investigated by any method established in the art, for example, using an oligonucleotide that specifically binds to a single set of gene nucleic acid sequences. Polymerase chain reaction (PCR), polymerase chain reaction combined with single-strand configuration polymorphism analysis (PCR-SSCP), denaturing gradient gel electrophoresis (DGGE) and nuclear enzyme A dislocation truncation method are several methods of the existing methods An example. It is worth noting that in addition to the single set of genes and SNPs mentioned here, genetic markers linked to any of the different sets of genes and SNPs can also be used to predict risk. This is because the genetic markers of a single set of genes and SNPs close to these targets will be separated from the target set, and will be separated or unbalanced due to SNPs. Therefore, the appearance of these markers (with genetic markers such as φ) indicates the presence of a single set of genes and SNPs, which indicates the risk of high blood pressure, high diglycerides, and/or metabolic syndrome. Equivalent to the mark. The mark can be any mark, including microsatellites and SNPs. Preferably, the effective genetic marker is derived from the ZPZ gene, which is about 200 kb or less. More preferably, it is derived from the LPL gene and is about i〇〇kb, 80kb, 60kb, 40kb, 20kb in size:

l^kb或5kb或更小。不平衡聯結可由技術領域中的熟知方法決 定’包括敘述於此的方法。 /N 本發明亦提供包含此述之SNP或單套基因型的核酸片段(單 股或雙股)。該片段可被用作探針。可被用來偵測單一㈣酸 套基因型的引子亦被提供。核酸片段或引子可被使用於各種組 12 1357442 合。舉例而言,偵測該單套基因的套組L^kb or 5kb or less. Unbalanced coupling can be determined by well-known methods in the art, including the methods described herein. /N The invention also provides nucleic acid fragments (single or double strands) comprising the SNPs described herein or a single set of genotypes. This fragment can be used as a probe. Primers that can be used to detect single (tetra) acid genotypes are also provided. Nucleic acid fragments or primers can be used in various groups 12 1357442. For example, detecting a set of genes

C/ΑΑ/Τ的三個SNPs的探針或引子。 ㈣早當巷U 相同地’針對單套基因型GTAG之四個SNPS的探針或引子, ϊίίί於—套财。錄組可獅㈣包含其她成物,如: •異種雜合設備及/或試劑 聚合酵素鏈鎖反應(PCR)設備及/或試劑 引子延展試劑 收集周邊血液的設備及/或試劑 其他寡聚核苷酸引子或探針 使用指示;及 •試劑容器 心if明進—步提供—方法,係可作為藥物基因學分析。因此, 疋SI人-部分的遺傳因子,且每—遺傳因子* — ,的患病傾向相關。根據本研究,單套基因型C、/AA/、T及^ 套基因型GTAG為針對高血壓、 及或早 標記。對於相同的嫛與心心—甘油月曰偏南或代謝症候群的 除了娜4冑-Λ症’或柯選擇性地包含其他遺傳因子。 予Ί或疾觸任何其他已知遺侧子,亦可包括於此。、 以下提供的實施例進一步闡明本發 啸佳實絲樣呈現並配合 神與賺林發明的精 實施例 實施例之内’下列縮寫具有下列涵義。 未疋義的縮寫具有其常用的涵義。 1357442Probes or primers for three SNPs of C/ΑΑ/Τ. (4) Early morning lane U is the same as the probe or primer for the four sets of genotype GTAG four SNPS, ϊίίί--crowd. The lion (4) can include other products, such as: • Heterogeneous hybrid equipment and/or reagents, polymerase chain reaction (PCR) equipment and/or reagent primer extension reagents, equipment and/or reagents for collecting peripheral blood. Nucleotide primers or probes are used as instructions; and • Reagent containers are provided as a method for pharmacogenomic analysis. Therefore, 疋SI human-partial genetic factors, and each genetic factor*, is associated with a predisposition. According to the present study, a single set of genotype C, /AA/, T, and genotype GTAG was targeted for hypertension, and early markers. For the same sputum and heart - glycerol sputum southerly or metabolic syndrome in addition to Na 4 胄 - Λ ’ or 柯 selectively contain other genetic factors. It may also be included in the sputum or in contact with any other known side. The following examples are provided to further illustrate the present invention and the following examples of the embodiments of the invention. Unspoken abbreviations have their usual meanings. 1357442

°c ~ 攝氏溫度 hr = 小時 min = 分鐘 sec or s = 秒 μΜ = 微莫耳 mM = 毫末耳 M = 莫耳(molar) ml = 毫升 μΐ = 微升 mg = = 毫克 pg = 微克 mol = 莫耳(mole) pmol = 微微莫耳 LPL HTN TG MS SBP DBP SNP = = 單一核皆酸多型性 PBS : = 磷酸鹽緩衝溶液 NTP = 三填核酸 PCR = 聚合酵素鏈鎖反應 NPL = 非參數聯結 ASO = 特化對偶寡核皆酸°c ~ Celsius temperature hr = hour min = minute sec or s = second μΜ = micromoles mM = milliamps M = mol ml ml = ml μΐ = microliters mg = = milligrams pg = micrograms mol = moles (mole) pmol = picomol LPL HTN TG MS SBP DBP SNP = = mononuclear acid polymorphic PBS : = phosphate buffer solution NTP = three-packed nucleic acid PCR = polymerase chain reaction NPL = non-parametric junction ASO = Specialized oligonucleic acid

14 1357442 材料及方法 (1)病人及家族 (A)初始之連鎖及相關研究 由2北榮民總醫院收集的21(H固高血壓臨床病人,來自分個 早發性高血壓核心家庭。於其巾,有25個兄祕妹對(pan,贫Μ 2000) 〇針對初始連鎖分析,其墜樣本在饥附近具有7個 微衛星標記基因型。加上後來收制❾9個具三酸甘油脂偏高(>= 150 mg/dL)的早發性高企壓家族,一共有267個對象被用於挪 的確認’以及構建说單套基因型,並用於下—步的家庭式相關 石if资。 (B)家庭式相關確認研究 該研究於在台灣西北部的三個客家地區收集資料。客家人為 攸大陸廣東省移民到台灣的中華漢人。早發性高血壓的先證^ ^obandj來自於4社區醫院。對於每一被確認的先證者,他/她的 豕庭成員均受遨進行血壓篩選及健康檢查。共收集了 345個族裔 及所包含的1002個家庭成員。於其中,384個早發性高血壓親子 φ 三人組(trios)被用於確認研究。中央研究院生物醫學科學研究所的 人類調查委員會已核准了本研究的步驟程序。 (2)高血壓的定義及相關表現型 符合任一以下條件,被定義為高血壓:(1)休息狀態的收縮壓 (SBP)高於或等於140毫米水銀柱,(2)舒張壓(DBP)高於或等於9〇 毫米水銀柱,(3)當下正在服用抗高血壓藥物。該高血壓病患發病 年齡在40歲以下,被定義為早發性的個案。此外,我們也在家庭 式相關研究中,使用另外兩種次表現型,(!)高血壓結合三酸甘 油脂偏高及(2)代謝症候群,。我們以空腹三酸甘油脂值高於或 專於150mg/dL來定義三酸甘油脂偏高,以修正的NCEp_ATp m 2002)21定義來定義代謝症候群。若至少符合下列三項 條件’即表示一個人具有代謝症候群:三酸甘油脂^15〇mg/dL、 男人之高密度脂蛋白膽固醇(HDL-C)<40 mg/dL/ 女人之面街度脂蛋白膽固醇<5〇 mg/dL、較高之體重指數(227)、 高血壓(收縮壓^135,舒張壓^85毫米水銀柱或是正在服用抗高 血壓藥物)、及空腹血糖>=110 mg/dL (或正在接受糖尿病治療)。 本研究採用台灣人的肥胖體重指數標準(見Pan et a丨心CAA 2〇〇4之 說明)22。 (3) 初始以微衛星標記基因型進行之連鎖及相關分析 用苯酚/氣仿萃取法收集59位先證者及其151位親屬的周圍淋 巴球’並分離之取得其基因體DNA(Aggarwaletal.,1992)23。位於 染色體8p22位置上有八種微衛星標記多型性,包含 D8S1731(31.73cM)、D8S261 (37.04cM)、D8S1145 (37.04cM)、 GZ-14/GZ-15 (GDB:177387 或 LPL 標記;39.25cM)、D8S322 (41.55cM)、D8S1116 (42.85cM)及 D8S382 (51.15cM)。微衛星標記 的基因型訂定步驟請見先前報告(pan et al,2000) 15。片段分析以 ABI377 DNA 定序機執行,並用 GeneScan version 3.0 及 genotyper version3.0分析。對偶基因檢測(aueie caning)及再確認由兩人獨立 執行。 (4) 發現及確認LPL基因之單一核苷酸多型性(SNPs) LPL基因具有10個外顯子,並跨距於第8號染色體短壁上約 30kb 〇 為了 在公開資料庫(http://www.ncbi.nlm.nih.gov/snpdatabase) 驗證被辨識的SNPs並且於中華漢族申發現更多新的SNPs,我們 將啟動子區域(取早發性高血壓家族中對正npl得分貢獻最 1357442 -多的41人)、肌編石馬區域之外顯子1-9 (41個對象)及選取的富含 已公開的SNPs的抓内含子的571個驗基對定序㈣咖職^过 al 1998)24。接著’我們將一 13獅、位於LpL區域内,僅包含少 數已知SNPs的内含子卜内含子2、及内含子3定序這部分的 DNA得自12個對象(6個早發性高血墨病患及6個年齡及性別與 其符合的血壓正常者)。 (5) SNPs基因型之不平衡聯結圖譜建構及相關研究 為了在^基因内建立不平衡聯結(LD)圖譜,將新辨識的 SNPs及確認的SNPs在來自267個中華漢人的DNA ,藉由籲 Mas?ARRAYSNP基因型訂定系統(8Ε(3υΕΝ〇Μ)分析定出(表 二)。聚合酵素鏈鎖反應利用20μ1内之l〇ng基因體DNA,以一14 1357442 Materials and methods (1) Patient and family (A) Initial linkage and related studies 21 (H-solid hypertension clinical patients collected from 2 North Rongmin General Hospital, from a family of early-onset hypertension cores. In the towel, there are 25 brothers and sisters (pan, poor 2000). For the initial linkage analysis, the sample has 7 microsatellite marker genotypes near the hunger. In addition, 9 triglycerides were collected later. A high-risk (>= 150 mg/dL) early-onset high-inflation family, a total of 267 subjects were used for the identification of the 'and the construction of a single genotype, and used for the family-related stone of the next step if (B) Family-related confirmation study The study collected data in three Hakka areas in northwestern Taiwan. The Hakkas were Chinese Han Chinese immigrants from Taiwan to Guangdong Province. The prognosis of early-onset hypertension ^ ^obandj comes from In 4 community hospitals, for each confirmed proband, his/her members of the court were subjected to blood pressure screening and health screening. A total of 345 ethnic groups and 1002 family members were included. , 384 early-onset hypertension parent-child φ trio ( Trios) was used to confirm the study. The Human Investigation Committee of the Institute of Biomedical Sciences of the Academia Sinica has approved the procedure for this study. (2) The definition of hypertension and related phenotypes are defined as any of the following conditions, defined as high Blood pressure: (1) systolic blood pressure (SBP) at rest is higher than or equal to 140 mm mercury column, (2) diastolic blood pressure (DBP) is higher than or equal to 9 mm mercury column, and (3) antihypertensive drugs are currently taking. Hypertensive patients under the age of 40 are defined as early-onset cases. In addition, we also use two other sub-phenotypes in family-related studies, (!) hypertension combined with triglyceride High and (2) metabolic syndrome. We define high triglyceride with a fasting triglyceride value higher than or specific to 150 mg/dL, and define metabolic syndrome as defined by the modified NCEp_ATp m 2002)21. If at least the following three conditions are met, it means that a person has metabolic syndrome: triglyceride ^15〇mg/dL, man's high-density lipoprotein cholesterol (HDL-C) <40 mg/dL/ woman's face street Lipoprotein cholesterol < 5 〇 mg / dL, higher body mass index (227), hypertension (systolic pressure ^ 135, diastolic pressure ^ 85 mm mercury column or taking antihypertensive drugs), and fasting blood glucose > 110 mg/dL (or receiving diabetes treatment). This study used the Taiwanese obese body mass index standard (see Pan et al., CAA 2〇〇4). (3) Initial linkage and correlation analysis with microsatellite marker genotypes The peripheral lymphocytes of 59 probands and their 151 relatives were collected by phenol/gas imitation extraction method and isolated to obtain their genomic DNA (Aggarwaletal. , 1992) 23. There are eight microsatellite marker polymorphisms at chromosome 8p22, including D8S1731 (31.73cM), D8S261 (37.04cM), D8S1145 (37.04cM), GZ-14/GZ-15 (GDB:177387 or LPL markers; 39.25 cM), D8S322 (41.55cM), D8S1116 (42.85cM) and D8S382 (51.15cM). The genotyping steps for microsatellite markers can be found in the previous report (pan et al, 2000). Fragment analysis was performed on an ABI377 DNA sequencer and analyzed using GeneScan version 3.0 and genotyper version 3.0. Dual gene detection (aueie caning) and reconfirmation were performed independently by two individuals. (4) Discovery and confirmation of single nucleotide polymorphisms (SNPs) of LPL genes The LPL gene has 10 exons and spans approximately 30 kb on the short wall of chromosome 8 for the purpose of accessing the database (http: //www.ncbi.nlm.nih.gov/snpdatabase) To verify the identified SNPs and discover more new SNPs in the Chinese Han nationality, we will use the promoter region (to contribute to the positive npl score in the early onset hypertension family) The most 1357442 - 41 people), the extensor 1-9 (41 subjects) outside the muscle-striped horse area, and the selected 571 bases of the captured introns of the published SNPs (4) Job ^ over 1998) 24. Then we will have a 13 lion, located in the LpL region, containing only a few known SNPs, introns 2, and intron 3, which are sequenced from 12 subjects (6 early onset) Sexually high blood-blooded patients and 6 normal blood pressures with age and gender. (5) Unbalanced Linkage Mapping of SNPs Genotypes and Related Studies In order to establish an unbalanced linkage (LD) map within the gene, newly identified SNPs and confirmed SNPs were obtained from DNA from 267 Chinese Han Chinese. Mas? ARRAYSNP genotyping system (8 Ε (3 υΕΝ〇Μ) analysis determined (Table 2). Polymerase chain reaction using 20 μl of l〇ng gene DNA, one

Perkim Elmer GeneAmp 9700 (Foster City,CA)熱循環機進行。最終 的試劑濃度為1倍的AmpliTaqGold PCR緩衝液(PE/ AppliedPerkim Elmer GeneAmp 9700 (Foster City, CA) thermal cycler. The final reagent concentration is 1x AmpliTaqGold PCR Buffer (PE/ Applied)

Biosystems,CA, USA) ’ 内含 2.5mM MgCl2、0.2mM dNTP、〇.2μΜ 各式引子及0.4UAmpliTaqGold。初始變性於94°C下進行15 min, 接著在94°C下進行45個每次20s的變性循環、於56°C下進行30 φ s的黏合’並於72°C下進行1 min的延展。最終延展於72°C下進 行3 min。PCR產物的延展由SNPs標記的延展引子,使用籲Biosystems, CA, USA) contains 2.5 mM MgCl2, 0.2 mM dNTP, 〇.2μΜ various primers and 0.4UAmpliTaqGold. The initial denaturation was carried out at 94 ° C for 15 min, followed by 45 denaturing cycles of 20 s at 94 ° C, 30 φ s bonding at 56 ° C and 1 min extension at 72 ° C. . The final extension was carried out at 72 ° C for 3 min. The extension of the PCR product is extended by the SNPs.

Homogeneous MassEXTEND spectroPREP™ (SEQUENOM)執行。 如第一圖所顯示’代表Bins B、D及F的9個SNP,選自確認研 究的1002個對象之SNPs基因型。於BinB的第二個SNP為插入 /刪除產生的多型性。 (6) 統計分析 針對初始研究,以多點連結分析,分析59個家族的25對罹 病的兄弟姊妹對的資料,使用GENEHUNTER程式(Kmglyak et al, 17 ⑤ 1357442 -1996)25執行。此外,來自35個家庭的42個早發性高血壓患者及 其义母的資訊’被用以執行親子傳輸不平衡測試 (Spidman and Ewens’ I"8)26。龐費洛尼考驗法(B〇nferr〇ni • Procedure)被用於調整多重比較26。廣義估計方程式(GEE Version2.〇3) (Liang KY et al,2001)27利用臨床化學資料,包含空腹 三酸甘油脂,比較早發性高血壓病患及未受影響近親間表現型的 不同。 為了建立LPZ基因的不平衡聯結(LD)圖譜,44個被確認的次 要對偶基因頻率(MAF) 20.05的SNPs,藉由G0LD(Graphical Overview of Linkage Disequilibrium)估計其連鎖不平衡區塊 (Abecasis et al,2000)28。考量以下參數,以進行SNPs的選擇及分 類:連鎖不平衡區塊的資訊(D’>0.8)、MAF是否大於等於〇j及是 否與結合的SNPs及外顯的SNPs重要相關。利用,TRANSMT,程 式(2.5.2, April 2000) (Clayton and Jones,1999)29 來進行特定單套基 因之傳輸不平衡測試。本分析中執行了 1〇〇〇〇次模擬檢驗 (bootstraps) ° 為了估計預測的高血壓及相關表現型之SNPs單套基因型風 φ 險對比值,使用 SIMWALK 程式(version 2.86,July 2003) (Sobel,Homogeneous MassEXTEND spectroPREPTM (SEQUENOM) is executed. The nine SNPs representing Bins B, D and F as shown in the first figure were selected from the SNPs genotypes of 1002 subjects that were confirmed to be studied. The second SNP at BinB is polymorphism resulting from insertion/deletion. (6) Statistical analysis For the initial study, data on 25 pairs of fraternal pairs of rickets in 59 families were analyzed by multi-point linkage analysis using the GENEHUNTER program (Kmglyak et al, 17 5 1357442-1996) 25. In addition, information on 42 patients with early-onset hypertension and their mothers from 35 families was used to perform the paternity transmission imbalance test (Spidman and Ewens' I"8)26. The Ponferroni test (B〇nferr〇ni • Procedure) is used to adjust multiple comparisons26. The generalized estimating equation (GEE Version 2, 〇 3) (Liang KY et al, 2001) 27 uses clinical chemistry data, including fasting triglycerides, to compare the phenotypes between early-onset hypertension and unaffected close relatives. In order to establish an unbalanced binding (LD) map of the LPZ gene, 44 confirmed SNPs with a minor gene frequency (MAF) of 20.05, and their linkage disequilibrium blocks were estimated by GD (Graphical Overview of Linkage Disequilibrium) (Abecasis et Al, 2000) 28. Consider the following parameters to select and classify SNPs: information on linkage disequilibrium blocks (D'>0.8), whether MAF is greater than or equal to 〇j, and whether they are importantly associated with combined SNPs and explicit SNPs. Use TRANSMT, Logic (2.5.2, April 2000) (Clayton and Jones, 1999) 29 to perform a transmission imbalance test for a specific set of genes. One analysis of bootstraps was performed in this analysis. To estimate the predicted value of a single set of genotypes of SNPs for predicted hypertension and related phenotypes, use the SIMWALK program (version 2.86, July 2003) ( Sobel,

Lange,Aw.仇肌Ge«说1996)30辨識確認研究當中的每一個人之 SNP單套基因型。多種8见>單套基因的危險對比值,使用(}££ 方法、SAS (SAS release 8.2)軟體進行估計。 實施例1 微衛星標記及早發性高血壓間的連鎖及相關分析 多點連鎖分析顯示,有一早發性高血壓的連鎖位置位於 基因内含子6 (GZ-14/GZ-15)附近,具一 npl指數為3 (獨立的受 影響近親對數為25)的基因標記的正向訊號。此外,藉由Lange, Aw. Qiu Ge Ge« said 1996) 30 identified the SNP single genotype of each individual in the study. A variety of 8 see > risk comparison values for a single set of genes were estimated using the (} £ £ method, SAS (SAS release 8.2) software. Example 1 Linkage and correlation analysis between microsatellite markers and early-onset hypertension Multi-point linkage Analysis showed that there is a linkage position of early-onset hypertension in the vicinity of gene intron 6 (GZ-14/GZ-15), with a npl index of 3 (independent independent relatives with a logarithm of 25) To the signal. In addition, by

Spielman的親子親傳輪不平衡測試(s_ D8S322有顯著相關(表一) 不了抓標把及 及D8S322的彻甘()饥己的對偶基因1 (p=1.5 X 1〇七) :====.8 x —遞至早發性高子代比 關!。如於其他對偶基因。因此,此分析顯示⑽與高血壓相 表一 標記 (cM) N E基而傳輪$合的巧¥合z指數- _ X5 Ϋ§~ 數 之ρ值 D8S1145 37Ό4 56 28Spielman's parent-child parental imbalance test (s_D8S322 has significant correlation (Table 1). The capture of the marker and the D8S322's Chegan () hunger-to-do dual gene 1 (p=1.5 X 1〇7) :==== .8 x — handed to early-onset high progeny than off!. As with other dual genes. Therefore, this analysis shows that (10) is associated with hypertension, one marker (cM), NE-based, and the same. Index - _ X5 Ϋ§~ Number of ρ values D8S1145 37Ό4 56 28

LPL 39.25 55 15 17 3 2.04 1.33 7.39 0.04 0.18 1.5χ1〇·13: 0.34 3.02 D8S322 41.55 49 J 1 38 % 4 24 2+ 38 4 6.23 3.05 5,50 4.6χΐ〇·1〇ϊ 0.002 3.8Χ10'8* 1.38 D8S1116 42.85 47 4 11 1 4 37 9 D8S382 51.15 45 3.49 1.68 1.75 0.0005 0.09 0.08 1.19 0.27 心^偶機f未ι生此現象時) * Ρ<1〇-5此AM代的數(當其他對偶機因發生此現象時) %>L·針對ϋ聯結分析的非參數對針對多重標記及對偶基因的調整 19 1357442 實施例2 高i壓病患及正常血壓者的臨床症狀比較 一初始相關性研究的臨床發現符合上述結果,高血壓病患的空 腹二酸甘油脂濃度(男 41 mg/dL、p=0.017 及女 33 mg/dL、p=〇.〇4) 大幅高於相同年齡、性別、居住地區及體重指數的正常控制組 (OienJW,/«/Ja^W,2004)。於確認研究當中,高血壓患者及未 文影響近親間的空腹三酸甘油脂濃度及大部分代謝症候群相關特 徵’包含體重指數、高密度脂蛋白膽固醇、膽固醇、空腹騰島素 及血糖,也有顯著的不同(表二)。 表二 確認研究中早發性高血壓個案及未受影響近親間代謝症候群相關 性狀之比較LPL 39.25 55 15 17 3 2.04 1.33 7.39 0.04 0.18 1.5χ1〇·13: 0.34 3.02 D8S322 41.55 49 J 1 38 % 4 24 2+ 38 4 6.23 3.05 5,50 4.6χΐ〇·1〇ϊ 0.002 3.8Χ10'8* 1.38 D8S1116 42.85 47 4 11 1 4 37 9 D8S382 51.15 45 3.49 1.68 1.75 0.0005 0.09 0.08 1.19 0.27 heart ^ couple machine f does not give birth to this phenomenon) * Ρ <1〇-5 the number of this AM generation (when other pairs of machines Because of this phenomenon) %>L·Adjustment of multiple markers and dual genes for nonparametric pairs of ϋ-linked analysis 19 1357442 Example 2 Comparison of clinical symptoms between high-pressure patients and normotensive patients: an initial correlation study The clinical findings are consistent with the above results. The fasting diglyceride concentration in male patients (41 mg/dL, p=0.017 and female 33 mg/dL, p=〇.〇4) is significantly higher than the same age, gender, and Normal control group of residential area and body mass index (OienJW, /«/Ja^W, 2004). In the confirmed study, the concentration of fasting triglyceride and most of the metabolic syndrome related to hypertensive patients and unaffected close relatives contained body mass index, high-density lipoprotein cholesterol, cholesterol, fasting tamsin and blood sugar. The difference (Table 2). Table 2 Comparison of traits related to metabolic syndrome in early-onset hypertension cases and unaffected relatives

高血壓個案 未受影響近親 差異t P值* ______平均 (95¾ CI) 男(224人)女(155人)男(161人)女(176人) 年齡(歲) 39.7±6.2 40.8±5.5 42_1±9.0 41.8±9.4 收縮壓(毫米水銀 柱) 139士18 137±18 124士17 118±18 19 (16.6-21.9) <0.0001 舒張壓(毫米水銀· 柱) 92±13 88±12 79±12 75±12 14 (11.9-15.6) <0.0001 體重指數(kg/m2) 27.4±3.9 26.0±4.4 25.1±3.1 23·9±3·8 2.2 (1.7〜2,7) <0.0001 腰圍(cm) 91.9±10.0 82.7 士 10.3 86.4±8.9 76.6 士 9·8 6.3 (4.9-7.7) <0.0001 三酸甘油脂 (mg/d〇 223±216 156±174 176±156 121 土 117 47 (25.1-69.0) <0.0001 高密度脂蛋白膽 固醇(mg/dl) 43 士 10 52±12 47±12 55 土 14 •2 (·4·2〜-0.7) 0.007 低密度脂蛋白膽 固醇(mg/dl) 129±51 125 土 33 124±32 116±33 9 (2.9-15.0) 0.004 1357442 膽固醇〇ng/dl) 211±58 202±42 200±40 191±36 14 (7.05-21.1) <0.0001 胰島素(IU/ml) 18士24 16 土 16 14±14 12±8 3 (0.9-4.8) 0.005 葡萄糖(mg/dl) 115士48 116±53 102±32 105±59 11 (3.04-18.6) 0.007 ^述資=係將345個家庭的資料用於混合模型以控制家庭間的關係,並使^性別及年齡作為共變異一 f未受影響之參考组 值用以比較對數轉換值Hypertensive cases unaffected in close relatives t P value * ___ average (953⁄4 CI) Male (224) female (155) male (161) female (176) Age (years) 39.7 ± 6.2 40.8 ± 5.5 42_1 ±9.0 41.8±9.4 Systolic pressure (mm mercury column) 139±18 137±18 124±17 118±18 19 (16.6-21.9) <0.0001 Diastolic pressure (mm mercury·column) 92±13 88±12 79±12 75 ±12 14 (11.9-15.6) <0.0001 Body Mass Index (kg/m2) 27.4±3.9 26.0±4.4 25.1±3.1 23·9±3·8 2.2 (1.7~2,7) <0.0001 Waist circumference (cm) 91.9 ±10.0 82.7 ±10.3 86.4±8.9 76.6 ±9·8 6.3 (4.9-7.7) <0.0001 Triglyceride (mg/d〇223±216 156±174 176±156 121 117 47 (25.1-69.0) &lt ;0.0001 high-density lipoprotein cholesterol (mg/dl) 43 ±10 52±12 47±12 55 soil 14 •2 (·4·2~-0.7) 0.007 low-density lipoprotein cholesterol (mg/dl) 129±51 125 Soil 33 124±32 116±33 9 (2.9-15.0) 0.004 1357442 Cholesterol 〇ng/dl) 211±58 202±42 200±40 191±36 14 (7.05-21.1) <0.0001 Insulin (IU/ml) 18士24 16土16 14±14 12±8 3 (0.9-4.8) 0.005 glucose (mg/dl) 115士48 11 6±53 102±32 105±59 11 (3.04-18.6) 0.007 ^Study=Use 345 household data for mixed models to control family relationships, and make gender and age as co-variation Affected reference group values are used to compare logarithmic conversion values

基因及建構單套基因之内的單一核皆酸多型性 的不平衡連鎖圖譜 為了找出高血壓風險相關的單套基因型及其他代謝症食 群相關症狀’ 基因中的44種MAF大於0.05的SNPs(表三 以267個人的DNA定出兩個主要的不平衡聯結圖譜區塊。我們名 抓基因的30kb的區域内建構了六個bins :於5,端的四個ld厘 塊(Bins A-D),及於3,端的兩個LD區塊(Bins E_F)(第一圖旬。方 其中,BinsB、D及F上的變異與高血壓相關。 ’Genes and constructs a single set of genes within a single nuclear polymorphism of the unbalanced linkage map in order to identify a single set of genotypes associated with hypertension risk and other metabolic syndrome-related symptoms '44 of the MAF in the gene is greater than 0.05 The SNPs (Table 3 identified two major unbalanced maps for the DNA of 267 individuals. We constructed six bins in the 30 kb region of our gene: four ld PCT at 5, Bins AD ), and two LD blocks at the 3' end (Bins E_F) (first TD. Among them, the variation on BinsB, D and F is related to hypertension.'

第-圖b顯示了於Bins B、D及F内最常見的單套基因。金 對Bm B (内含子3-4) ’其中顯示了三種多型性(s鹏為洲、 SNP為必2及SNP6為以53)。Bin B中最常見 m的單套基因型為c/aa/t, 目於1Bin D(内含子5·6) ’風險相_單套基因 p S 〇"13,^^,J^AF050163-25〇〇'rs269^rs27( 及rs 1)。於Bm F(外顯子8_9)巾的風險相關 SNPs 30及38 (rs328))。 干去丞u i两…(方、 ⑤ 21 1357442 表三 於台灣族群中的脂蛋白脂分解酶基因多型性變異及其對偶基因頻 率 多型性 多型性 _(對偶基因頻率yi . , 於NCBI 基因庫NT 030737 標記名稱 標記_爽之位置 號碼 ~ 结尾 於NT_030737* 於台灣人中Figure-b shows the most common single set of genes in Bins B, D and F. Gold vs. Bm B (intron 3-4)' shows three polymorphisms (s Pengzhou, SNP 2 and SNP6 53). The single genotype of the most common m in Bin B is c/aa/t, and the target is 1Bin D (intron 5·6) 'risk phase_single set of genes p S 〇"13,^^,J^AF050163 -25〇〇'rs269^rs27( and rs 1). Risk-related SNPs 30 and 38 (rs328) for Bm F (exon 8_9) towels. Dry to 丞ui two...(方, 5 21 1357442 Table 3: Polymorphism of lipoprotein lipolytic enzyme gene in Taiwanese population and polymorphic polymorphism of its dual gene frequency _ (dual gene frequency yi . Gene bank NT 030737 tag name tag _ 爽 location number ~ ending at NT_030737* in Taiwanese

LPL-1322 7606407 7606407 — A/G (0.96/0.04) A⑽ 一 P1-1 7606596 7606596 G/T (rsl470187) G(1.0) X P1-2 7606710 7606710 T/C(rs 1470186) T(1.0) X LPL-53 7607528 7607528 — C/A (0.83/0.17) C(1.0) 外顯子1 7607873 7607960 — 7608249 7608249 G/T (rs2898492) G(T〇) x … 11-2 7608837 7608837 G/T (rs3779787) G/T (0.71/0.29)* X 11-4 7610208 7610208 — A/C (0.96/0.04) X LPL-55 1 7610562 7610562 (rsl534649) G/T (0.71/0.29)* G/T (0.89/0.11) 11-7-1 7612033 7612033 G/A (rs 1031045) G(1.0) X LPL-1323 7612451 7612451 — T/G (0.67/0.33) X 11-9 76i3323 7613323 — C/T (0.71/0.29)* X 11-10 7613481 7613481 — G/A (0.96/0.04) X 11-11-1 7613779 7613779 — A/C (0.96/0.04) A (1.0) 11-11-2 7614014 7614014 C/T (rs3779788) C/T (0.71/0.29)* X 11-13-1 7614752 7614752 — G/A (0.96/0.04) X 11-13-2 7614917 7614917 一 T/A (0.71/0.29)* X 1外顯子2 7616612 7616772 — LPL-E2 7616629 7616629 Asp9 一 Asn G(H)厂…—… LPL-186811 2 7617592 7617592 C/G(rs8176337) C/G (0.71/0.29) C/G (0.89/0.11) 外顯子3 7620201 7620380 — LPL-E3-1 7620215 79620215 Tyr61—stop T(l.O)" — LPL-E3-2 7620356 7620356 G/A (rsl 121923) G(1.0) 7621122 7621122 T/C(rs8176338) T/C (0.96/0.04) T/C (0.99/0.01) LPL-1871 3 7621708 7621708 C/A(rs343) C/A (0.79/0.21) C/A (0.87/0· 13) 7621712 7621712 A/C (rs247) A (1.0) X ;外顯子4 7621742 7621853 — •〜. LPL-E4 7621747 7621747 G/A(rs248) G(1.0) rs249 4 7621927 7621927 T/C (rs249) T/C (0.94/0.06) T/C (0.93/0.07) P4 1 1 7621945 7621945 T-/TG/GT (rs250) T(I.O) T(1.0) 7622081 7622081 T/C(rs251) T(1.0) X P4 1 23 5 7622153 7622153 A/· (rs252) AAA/AA AAA/AA (0.75/0.25) (0.63/0.37) P4 1 4 6 7622338 7622338 T/C (rs253) T/C (0.6/0.4) T/C (0.61/0.39) 外釦孚5 7622552 7622785 — LPL-E5-1 7622617 7622617 G/A (Ala176—Thr) G(1.0) LPL-E5-2 7622654 7622654 G/A (Gly188^Glu) G(1.0) LPL-E5-3 7622672 7622672 T/C (Ile194^Thr) T(1.0) LPbE5-4 7622703 7622703 C/G (Asp2°4—Glu) C(1.0) P4 2 1 7 7622818 7622818 C/G (rs254) C/G C/G (0.83/0.17) (0.625/0.375)tf P4_2_2 7622822 7622822 T/C (rs255) T/C (0.625/0.3 75)n X 7622888 7622888 C/T (rs256) C(1.0) X 22 1357442LPL-1322 7606407 7606407 — A/G (0.96/0.04) A(10) A P1-1 7606596 7606596 G/T (rsl470187) G(1.0) X P1-2 7606710 7606710 T/C(rs 1470186) T(1.0) X LPL -53 7607528 7607528 — C/A (0.83/0.17) C(1.0) Exon 1 7607873 7607960 — 7608249 7608249 G/T (rs2898492) G(T〇) x ... 11-2 7608837 7608837 G/T (rs3779787) G/T (0.71/0.29)* X 11-4 7610208 7610208 — A/C (0.96/0.04) X LPL-55 1 7610562 7610562 (rsl534649) G/T (0.71/0.29)* G/T (0.89/0.11 11-7-1 7612033 7612033 G/A (rs 1031045) G(1.0) X LPL-1323 7612451 7612451 — T/G (0.67/0.33) X 11-9 76i3323 7613323 — C/T (0.71/0.29)* X 11-10 7613481 7613481 — G/A (0.96/0.04) X 11-11-1 7613779 7613779 — A/C (0.96/0.04) A (1.0) 11-11-2 7614014 7614014 C/T (rs3779788) C /T (0.71/0.29)* X 11-13-1 7614752 7614752 — G/A (0.96/0.04) X 11-13-2 7614917 7614917 One T/A (0.71/0.29)* X 1 Exon 2 7616612 7616772 — LPL-E2 7616629 7616629 Asp9 an Asn G(H) factory...—... LPL-186811 2 7617592 7617592 C/G (rs8176337 C/G (0.71/0.29) C/G (0.89/0.11) Exon 3 7620201 7620380 — LPL-E3-1 7620215 79620215 Tyr61—stop T(lO)" — LPL-E3-2 7620356 7620356 G/ A (rsl 121923) G(1.0) 7621122 7621122 T/C(rs8176338) T/C (0.96/0.04) T/C (0.99/0.01) LPL-1871 3 7621708 7621708 C/A(rs343) C/A (0.79 /0.21) C/A (0.87/0·13) 7621712 7621712 A/C (rs247) A (1.0) X ; exon 4 7621742 7621853 — •~. LPL-E4 7621747 7621747 G/A(rs248) G( 1.0) rs249 4 7621927 7621927 T/C (rs249) T/C (0.94/0.06) T/C (0.93/0.07) P4 1 1 7621945 7621945 T-/TG/GT (rs250) T(IO) T(1.0) 7622081 7622081 T/C(rs251) T(1.0) X P4 1 23 5 7622153 7622153 A/· (rs252) AAA/AA AAA/AA (0.75/0.25) (0.63/0.37) P4 1 4 6 7622338 7622338 T/C (rs253) T/C (0.6/0.4) T/C (0.61/0.39) Outer buckle 5 7622552 7622785 — LPL-E5-1 7622617 7622617 G/A (Ala176—Thr) G(1.0) LPL-E5-2 7622654 7622654 G/A (Gly188^Glu) G(1.0) LPL-E5-3 7622672 7622672 T/C (Ile194^Thr) T(1.0) LPbE5-4 7622703 7622703 C/G (Asp2°4—Glu C(1.0) P4 2 1 7 7622818 7622818 C/G (rs254) C/GC/G (0.83/0.17) (0.625/0.375) tf P4_2_2 7622822 7622822 T/C (rs255) T/C (0.625/0.3 75 ) n X 7622888 7622888 C/T (rs256) C(1.0) X 22 1357442

標記名稱 標記 號碼 t 於 NCBI 基因庫 NT_030737 號之位置 多型性 多型性 開始 結尾 於 NT—030737* (公開>^稱) 於台灣人t (對偶基因頻率) (對偶基因頻率)n 7623149 7623149 A/C (rs257) A (1.0) X P5_l 8 7623173 7623173 G/C (rs258) G/C (0.5/0.5) G/C (0.60/0.40) 7623358 7623358 A/T(rs259) A (1.0) X 7623420 7623420 C/G (rs260) C(l.〇) X 7623541 7623541 A/G A (1.0) X (AF050163-1939) 7623563 7623563 ATT A (1.0) X (AF050163-1961) P5 一 2 9 7623733 7623733 C/T C/T (0.65/0.35) C/T (0.73/0.27) (AF050163-2131) P5 一 3 10 7624101 7624101 G/A G(1.0) G/A (0.82/0.18) (AF050163-2500) rs265 7624190 7624190 C/G (rs265) X C(1.0) rs266 7624220 7624220 A/G (rs266) X A (1.0) rs267 7624239 7624239 C/T(rs267) X X 外顯子6 7624273 7624515 — ; LPL-E6-1 7624359 7624359 G/A (Ala261—f lir) G(l.O) LPL-E6-2 7624450 7624450 A/G (Asn291—Ser) A (1.0) LPL-1325 11 7624588 7624588 T/G (rs269) T/G (0.64/0.36) T/G (0.83/0.17) 7624589 7624589 G/T (rs2075651) G(1.0) X LPL-56 12 7624597 7624597 C/A (rs270) C/A (0.91/0.09) C/A (0.82/0.18) LPL-57 13 7624623 7624623 G/A(rs271) G/A (0.64/0.36) G/A (0.82/0.18) 7624849 7624849 C/G (rs272) C(1.0) X 7625154 7625154 C/T (rs275) C(1.0) X 7625210 7625210 T/C (rs276) T(1.0) X LPL-58 14 7625444 7625444 — G/A (0.91/0.09) G/A (0.82/0.18) 7625617 7625617 C/G (rs279) X X 7625803 7625803 G/A(rs280) G(1.0) X LPL-59 15 7625944 7625944 A/T(rs281) A/T (0.77/0.23) A/T (0.72/0.28) LPL-60 7625947 7625947 C/G (rs282) C(1.0) C(1.0) LPL-61 7625968 7625968 — T/C (0.96/0.05) T/C (0.99/0.01) LPL-62 16 7626019 7626019 CAT (rs283) C/T (0.82/0.18) C/T (0.80/0.20) LPL-63 7626027 7626027 T/C (rs284) T(1.0) T(1.0) LPL-64 17 7626110 7626110 C/T (rs285) X CAT (0.63/0.37) LPL-65 7626177 7626177 A/T (rs286) X A(l.O) LPL-130 18 7626477 7626477 A/G (rs6586882) A/G (0.75/0.25) A/G (0.83/0.17) 7626522 7626522 G/A(rs2583659) G(1.0) X LPL-131 19 7626540 7626540 T/C (rs2853630) T(1.0) T/C (0.84/0.16) LPL-132 7626759 7626759 G/A(rs2698206) G(1.0) G(1.0) LPL-133 20 7626773 7626773 T/C(rs291) T/C (0.7/0.3) T/C (0.92/0.08) 7626976 7626976 G/A(rs292) G(1.0) X P8 2 1 7627000 7627000 A/- (rs293) A/-(0.0/1.0) X P8 2 2 7627046 7627046 T/C (rs294) T(1.0) X P8 2 3 21 7627159 7627159 A/C (rs295) A/C (0.94/0.06) A/C (0.85/0.15) 7627165 7627165 G/A (rs296) G(1.0) X P8_2_4 7627292 7627292 T/C (rs297) T(1.0) X 外7 7627692 7627812 — LPL-E7-1 7627781 7627781 G/A (rs298) G(1.0) LPL-E7-2 7627801 7627801 C/T(rs299) C(1.0) LPL-E7-3 7627808 7627808 A/G (rs300) A (1.0) LPL-66 22 7627855 7627855 T/C(rs301) T/C (0.68/0.32) T/C (0.83/0.17) 23 1357442 於NCB1基因庫ΝΤ_030737 多型性Marker name tag number t at the NCBI gene bank NT_030737 position polymorphism polymorphism begins at NT-030737* (publication > ^) in Taiwanese t (dual gene frequency) (dual gene frequency) n 7623149 7623149 A/C (rs257) A (1.0) X P5_l 8 7623173 7623173 G/C (rs258) G/C (0.5/0.5) G/C (0.60/0.40) 7623358 7623358 A/T(rs259) A (1.0) X 7623420 7623420 C/G (rs260) C(l.〇) X 7623541 7623541 A/GA (1.0) X (AF050163-1939) 7623563 7623563 ATT A (1.0) X (AF050163-1961) P5 a 2 9 7623733 7623733 C/ TC/T (0.65/0.35) C/T (0.73/0.27) (AF050163-2131) P5 - 3 10 7624101 7624101 G/AG(1.0) G/A (0.82/0.18) (AF050163-2500) rs265 7624190 7624190 C /G (rs265) XC(1.0) rs266 7624220 7624220 A/G (rs266) XA (1.0) rs267 7624239 7624239 C/T(rs267) XX Exon 6 7624273 7624515 — ; LPL-E6-1 7624359 7624359 G/A (Ala261—f lir) G(lO) LPL-E6-2 7624450 7624450 A/G (Asn291—Ser) A (1.0) LPL-1325 11 7624588 7624588 T/G (rs269) T/G (0.64/0. 36) T/G (0.83/0.17) 7624589 7624589 G/T (rs2075651) G(1.0) X LPL-56 12 7624597 7624597 C/A (rs270) C/A (0.91/0.09) C/A (0.82/0.18 LPL-57 13 7624623 7624623 G/A(rs271) G/A (0.64/0.36) G/A (0.82/0.18) 7624849 7624849 C/G (rs272) C(1.0) X 7625154 7625154 C/T (rs275) C(1.0) X 7625210 7625210 T/C (rs276) T(1.0) X LPL-58 14 7625444 7625444 — G/A (0.91/0.09) G/A (0.82/0.18) 7625617 7625617 C/G (rs279) XX 7625803 7625803 G/A(rs280) G(1.0) X LPL-59 15 7625944 7625944 A/T(rs281) A/T (0.77/0.23) A/T (0.72/0.28) LPL-60 7625947 7625947 C/G ( Rs282) C(1.0) C(1.0) LPL-61 7625968 7625968 — T/C (0.96/0.05) T/C (0.99/0.01) LPL-62 16 7626019 7626019 CAT (rs283) C/T (0.82/0.18) C/T (0.80/0.20) LPL-63 7626027 7626027 T/C (rs284) T(1.0) T(1.0) LPL-64 17 7626110 7626110 C/T (rs285) X CAT (0.63/0.37) LPL-65 7626177 7626177 A/T (rs286) XA(lO) LPL-130 18 7626477 7626477 A/G (rs6586882) A/G (0.75/0.25) A/G (0.83/0.17) 7626522 7626522 G/A(rs2583659) G(1.0 ) X LPL-131 19 7626540 7626540 T/C (rs2853630) T(1.0) T/C (0.84/0.16) LPL-132 7626759 7626759 G/A(rs2698206) G(1.0) G(1.0) LPL-133 20 7626773 7626773 T/C(rs291 T/C (0.7/0.3) T/C (0.92/0.08) 7626976 7626976 G/A(rs292) G(1.0) X P8 2 1 7627000 7627000 A/- (rs293) A/-(0.0/1.0) X P8 2 2 7627046 7627046 T/C (rs294) T(1.0) X P8 2 3 21 7627159 7627159 A/C (rs295) A/C (0.94/0.06) A/C (0.85/0.15) 7627165 7627165 G/A ( Rs296) G(1.0) X P8_2_4 7627292 7627292 T/C (rs297) T(1.0) X Outer 7 7627692 7627812 — LPL-E7-1 7627781 7627781 G/A (rs298) G(1.0) LPL-E7-2 7627801 7627801 C/T(rs299) C(1.0) LPL-E7-3 7627808 7627808 A/G (rs300) A (1.0) LPL-66 22 7627855 7627855 T/C(rs301) T/C (0.68/0.32) T/C (0.83/0.17) 23 1357442 in the NCB1 gene bank ΝΤ _030737 polymorphism

標記名稱 標記 號碼 t 號之位置 多型性 開始 结尾 於 ΝΤ_030737; (公開i"稱) 於台灣人中 (對偶基因頻率) (對偶基因頻率)11 LPL-67 7627888 7627888 C/T (rs302) C(l.〇) X LPL-134 23 7628200 7628200 G/C (rs303) G/C (0.95/0.05) G/C (0.91/0.09) LPL-135 24 7628282 7628282 T/G (rs 1963909) T/G (0.7/0.3) T/G (0.83/0.17) LPL-136 25 7628322 7628322 A/G (rs2244603) A/G (0.7/0.3) A/G (0.83/0.17) LPL-137 26 7628397 7628397 — T/G (0.85/0.15) T/G (0.93/0.07) LPL-138 27 7628467 7628467 C/T (rs2853631) c/τ (0.90/0.10) C/T (0.91/0.09) LPL-150 7628543 7628543 AAAT/- (rs311) AAAT (1.0) AAAT (1.0) LPL-68 28 7628918 7628918 G/C(rs312) G/C (0.92/0.08) G/C (0.91/0.09) LPL-69 7628947 7628947 A/G(rs313) A (1.0) X LPL-70 29 7628963 7628963 G/A(rs314) G/A (0.63/0.38) G/A (0.83/0.17) LPL-71 7629016 7629016 T/C(rs315) T(1.0) X 外翱子8 7629333 7629515 LPL-E8-1 30 7629357 7629357 C/A (Thr361—Thr) C/A (0.83/0.17) C/A (0.91/0.09) LPL-E8-2 7629472 7629472 G/A(Ala400—Thr) G(1.0) Rs317 31 7629692 7629692 AG/-orGn"(rs317)x G/T (0.91/0.09) LPL-72 7629890 7629890 C/G(rs318) C(1.0) C(1.0) LPL-73 32 7629897 7629897 A/C(rs3l9) A/C (0.86/0.14) A/C (0.80/0.20) LPL-74 33 7629998 7629998 T/G (rs320) T/G (0.68/0.32) T/G (0.83/0.17) LPL-75 7630107 7630107 G/C(rs321) G (1.0) G(1.0) LPL-76 34 7630138 7630138 A/C (rs322) A/C (0.68/0.32) A/C (0.83/0.17) 7630142 7630142 A/C (rs323) A (1.0) X 7630143 7630143 A/- (rs324) A (1.0) X LPL-77 35 7630249 7630249 T/C (rs325) T/C (0.73/0.27) T/C (0.92/0.08) LPL-78 36 7630360 7630360 A/G (rs326) A/G (0.68/0.32) A/G (0.83/0.17) LPL-79 _37_ 7630457 7630457 T/G (rs327) T/G (0.70/0.30) T/G (0,83/0.17) :外巔子9 7630547 7630651 * * * ..............- LPL-E9 38 7630645 7630645 C/G (Ser447—stop) C/G (0.95/0.05) C/G (0.92/0.08) (rs328) 7631007 7631007 A/G (rs329) A (1.0) x LPL-80 39 7631317 7631317 G/A (rs330) G/A (0.92/0.08) G/A (0.91/0.09) LPL-81 40 7631326 7631326 G/A (rs331) G/A (0.92/0.08) G/A (0.83/0.17) :福 ΤΰΓ 7633742 7635690 1(3’未轉譯區) Ρ13-1 7634113 7634113 T/C (rs3289) T/C (0.96/0.04) T/C (0.996/0.004) 7634567 7634567 G/A (rs 1059497) G(1.0) X LPL-1324 41 7634569 7634569 A/T (rs3208305) A/T (0.56/0.44) A/T (0.84/0.16) Ρ13 一3_1 42 7634595 7634595 _ C/T (0.73/0.27) C/T (0.9/0.10) Ρ13_3_2 7634884 7634884 C/T (rsl059507) C/T (0.95/0.05) x P14_l 43 7635413 7635413 T/C (rsl 3702) T/C (0.73/0.27) T/C (0.86/0.14) Ρ14_2 44 7635484 7635484 T/C (rs 1059611) T/C (0.77/0.23) T/C (0.92/0.08) Ρ14_3 7635588 7635588 C/T (rsl 5285) C/T (0.71/0.29) X Ρ14_4 7635600 7635600 C/A (rs386647) C/A (0.96/0.04) X Ρ14 一 5 7635789 7635789 C/A(rs3916027) G/A (0.71/0.29) X :用於LD及TDT分析的單一核苷酸多型性的序列號碼顯示於第一圖及表三》-The position polytype of the tag name tag number t begins to end at ΝΤ_030737; (public i"called) in Taiwanese (dual gene frequency) (dual gene frequency) 11 LPL-67 7627888 7627888 C/T (rs302) C( L.〇) X LPL-134 23 7628200 7628200 G/C (rs303) G/C (0.95/0.05) G/C (0.91/0.09) LPL-135 24 7628282 7628282 T/G (rs 1963909) T/G ( 0.7/0.3) T/G (0.83/0.17) LPL-136 25 7628322 7628322 A/G (rs2244603) A/G (0.7/0.3) A/G (0.83/0.17) LPL-137 26 7628397 7628397 — T/G (0.85/0.15) T/G (0.93/0.07) LPL-138 27 7628467 7628467 C/T (rs2853631) c/τ (0.90/0.10) C/T (0.91/0.09) LPL-150 7628543 7628543 AAAT/- ( Rs311) AAAT (1.0) AAAT (1.0) LPL-68 28 7628918 7628918 G/C(rs312) G/C (0.92/0.08) G/C (0.91/0.09) LPL-69 7628947 7628947 A/G(rs313) A (1.0) X LPL-70 29 7628963 7628963 G/A(rs314) G/A (0.63/0.38) G/A (0.83/0.17) LPL-71 7629016 7629016 T/C(rs315) T(1.0) X Sub 8 8629333 7629515 LPL-E8-1 30 7629357 7629357 C/A (Thr361—Thr) C/A (0.83/0.17) C/A (0.91/0.09) LPL-E8-2 7629 472 7629472 G/A(Ala400—Thr) G(1.0) Rs317 31 7629692 7629692 AG/-orGn"(rs317)x G/T (0.91/0.09) LPL-72 7629890 7629890 C/G(rs318) C(1.0) C(1.0) LPL-73 32 7629897 7629897 A/C(rs3l9) A/C (0.86/0.14) A/C (0.80/0.20) LPL-74 33 7629998 7629998 T/G (rs320) T/G (0.68/ 0.32) T/G (0.83/0.17) LPL-75 7630107 7630107 G/C(rs321) G (1.0) G(1.0) LPL-76 34 7630138 7630138 A/C (rs322) A/C (0.68/0.32) A /C (0.83/0.17) 7630142 7630142 A/C (rs323) A (1.0) X 7630143 7630143 A/- (rs324) A (1.0) X LPL-77 35 7630249 7630249 T/C (rs325) T/C (0.73 /0.27) T/C (0.92/0.08) LPL-78 36 7630360 7630360 A/G (rs326) A/G (0.68/0.32) A/G (0.83/0.17) LPL-79 _37_ 7630457 7630457 T/G (rs327 T/G (0.70/0.30) T/G (0,83/0.17): outer tweezers 9 7630547 7630651 * * * ..............- LPL-E9 38 7630645 7630645 C/G (Ser447—stop) C/G (0.95/0.05) C/G (0.92/0.08) (rs328) 7631007 7631007 A/G (rs329) A (1.0) x LPL-80 39 7631317 7631317 G/A ( Rs330) G/A (0.92/0.08) G/A (0.91/0.09) LPL-81 40 7631326 7631326 G/A (rs331) G/A (0.92/0.08) G/A (0.83/0.17): Well-being 7633742 7635690 1 (3' untranslated area) Ρ13-1 7634113 7634113 T/C (rs3289) T/C ( 0.96/0.04) T/C (0.996/0.004) 7634567 7634567 G/A (rs 1059497) G(1.0) X LPL-1324 41 7634569 7634569 A/T (rs3208305) A/T (0.56/0.44) A/T ( 0.84/0.16) Ρ13 33_1 42 7634595 7634595 _ C/T (0.73/0.27) C/T (0.9/0.10) Ρ13_3_2 7634884 7634884 C/T (rsl059507) C/T (0.95/0.05) x P14_l 43 7635413 7635413 T /C (rsl 3702) T/C (0.73/0.27) T/C (0.86/0.14) Ρ14_2 44 7635484 7635484 T/C (rs 1059611) T/C (0.77/0.23) T/C (0.92/0.08) Ρ14_3 7635588 7635588 C/T (rsl 5285) C/T (0.71/0.29) X Ρ14_4 7635600 7635600 C/A (rs386647) C/A (0.96/0.04) X Ρ14 a 5 7635789 7635789 C/A(rs3916027) G/A (0.71/0.29) X: The sequence number of a single nucleotide polymorphism for LD and TDT analysis is shown in Figure 1 and Table 3 -

J用於變異的公開單一核苷酸多型性得自於NT_008081 (2001 April version)及Ντ 〇〇827丨(2〇〇1 October version) *> 一 、 用於定序的12個台灣人樣本(6高血壓病患及6正常血壓者控制組)_然而,針對外起;罝_4钵赭 多型性’樣本來自於早發性高血壓家族的41個目標(見方法)。 " 用^決定對偶基因頻率的樣本,為初始研究中的267個目標》 *,具此符號的單一核苷酸多型性與另一者具完全不平衡聯結。 24 442 i^8^^^337)及LPL]87Q㈣176338):細將這些單—㈣衫雖送至NCBI之單一核發 ―:非多型性;X:位被訂定基因型 實施例4 傳輸不平衡分析中之單一核苷酸多型性與早發性高血壓及其他代 謝症候群相關表現型之關聯性 於初始研九中對267個個案的分析研究發現,與確認研究中 單套基因及高血壓不平衡傳輸分析的相關性,所得結果一 致二於確認相關研究中,使用了 15〇5個個案資料(由原1〇〇2個人 的貧料擴增)(表四)。針對三酸甘油脂偏高(p=〇 〇〇5)、針對高血壓 結合三酸甘油脂偏高(Ρ<0·0001),及針對代謝症候群&=〇 〇3),Bin B的單套基因型C/AA/T傳遞至子代的比例顯著高於其他。相反 的,針對咼血壓及二酸甘油脂偏高結合表現型,區塊B的單套基 因型C/AAA/C傳遞至子代之情形_較低。關於Bin D,針對高 血壓結合三酸甘油脂偏高之表型,單套基因型GTCG&GTAG傳 遞至子代的情形,分別是顯著較低及較高&<〇 〇〇〇1); 於Bm D Η的單套基因邊GTAG,也發現與高血壓及代謝症候群 呈正相關,但相關程度較小。針對BinF,單套基因CG分別針對 三酸甘油脂偏高及高血壓有傳遞至子代較少的現像 〇4 P=0.03)。 ’ 1357442J. The disclosed single nucleotide polymorphism for variation was obtained from NT_008081 (2001 April version) and Ντ 〇〇827丨 (2〇〇1 October version) *> 1. 12 Taiwanese used for sequencing Samples (6 hypertensive patients and 6 normal blood pressure control groups) _ However, for the external; 罝_4钵赭 polymorphic 'samples from 41 targets of the early-onset hypertension family (see method). " Use ^ to determine the frequency of the dual gene, which is the 267 targets in the initial study. *, the single nucleotide polymorphism with this symbol is completely unbalanced with the other. 24 442 i^8^^^337) and LPL]87Q (4) 176338): These single-(four) shirts are sent to the NCBI's single nuclear hair--: non-polymorphic; X: bit is set genotype embodiment 4 transmission is not Correlation between single nucleotide polymorphism in equilibrium analysis and phenotypes associated with early-onset hypertension and other metabolic syndromes. In the initial study, 267 cases were analyzed and found in a single set of genes and high in the validation study. Correlation of blood pressure imbalance transmission analysis, the results obtained were consistent. In the confirmation study, 15 to 5 case data were used (expanded by the poor materials of the original 1〇〇2 individuals) (Table 4). High for triglycerides (p=〇〇〇5), high for triglycerides for hypertension (Ρ<0·0001), and for metabolic syndrome &=〇〇3), Bin B The proportion of genotype C/AA/T delivered to progeny was significantly higher than the others. Conversely, for the combined phenotype of sputum blood pressure and diglyceride, the single set of genotype C/AAA/C of block B was passed to the offspring _ lower. Regarding Bin D, for the high phenotype of hypertension combined with triglyceride, the single genotype GTCG & GTAG was transferred to the offspring, which were significantly lower and higher &<〇〇〇〇1) A single set of gene-side GTAG in Bm D 也 was also found to be positively correlated with hypertension and metabolic syndrome, but to a lesser extent. For BinF, a single set of gene CG is targeted for high levels of triglycerides and high blood pressure, which is transmitted to fewer offspring (〇4 P=0.03). ‘ 1357442

$ ^ HQH ^ 1^ ^s,, ^.ί ^ , 4^$sws0 βοοο^ s< \~¥ 〇. 0.269 0.034 0.067 0.037 0.446 0.208 0.076 0.094 Β in F (單一核苷酸多型性30,38) t ν〇 Ο $ 2 407 58 § ^ Obs S — 异ON 415 50 g - 單套基因 α α υ υ 8 8 u a u u U 〇 U U Z 253 2 (Ν BinD單一核苷酸多型性10,丨1,12, 13” 〇. 0.149 0.049 0.330 0.062 <0.0001 * <0.0001 * 0.720 0.022 ^ CN ν〇 IT) — 319 75 R - Obs CN «•/Ί 对 ^Τϊ — 312 92 單套基因 GTCG GTAG GTCG GTAG GTCG GTAG GTCG GTAG 2 435 2 οο Γ^ί (Ν Bin B (單一核苷酸多型性3,5,6)1 Q. 0.665 0.176 0.485 0.005* 0.007* <0.0001* 0.875 0.033 卜 00 m οο m — 〇〇 in Os O (N — a 卜 σ\ (Ν 00 ο CN — Obs iT) ON — 294 118 cn (NO (N — οο γλ οο — (Ν — 單套基因§ C/AAA/C C/AA/T C/AAA/C C/AAJT C/AAA/C C/AA/T C/AAA/C C/AA/T Z 427 243 § (Ν m (Ν 表現型卞 高血歷 三酸甘油脂 偏向 尚_ώ·壓結合 三酸甘油脂 偏尚 代謝症候群 . ϊ— - * ΠΠ鵷忘鳍敢sE:dx3ii柘宕>不齙轮制叫續#回靖#許v^sqom^s齙磙制:z ____-¾0^-^$ ^ HQH ^ 1^ ^s,, ^.ί ^ , 4^$sws0 βοοο^ s< \~¥ 〇. 0.269 0.034 0.067 0.037 0.446 0.208 0.076 0.094 Β in F (single nucleotide polymorphism 30,38 t ν〇Ο $ 2 407 58 § ^ Obs S - Iso-ON 415 50 g - Single set of genes α α υ υ 8 8 uauu U 〇UUZ 253 2 (Ν BinD single nucleotide polymorphism 10, 丨 1, 12, 13" 〇. 0.149 0.049 0.330 0.062 <0.0001 * <0.0001 * 0.720 0.022 ^ CN ν〇IT) — 319 75 R - Obs CN «•/Ί 对^Τϊ — 312 92 Single set of genes GTCG GTAG GTCG GTAG GTCG GTAG GTCG GTAG 2 435 2 οο Γ^ί (Ν Bin B (single nucleotide polymorphism 3,5,6)1 Q. 0.665 0.176 0.485 0.005* 0.007* <0.0001* 0.875 0.033 卜 00 m οο m — 〇〇in Os O (N — a 卜σ\ (Ν 00 ο CN — Obs iT) ON — 294 118 cn (NO (N — οο γλ οο — (Ν — Single set of genes § C/AAA/CC/AA /TC/AAA/CC/AAJT C/AAA/CC/AA/TC/AAA/CC/AA/TZ 427 243 § (Ν m (Ν 卞 卞 卞 血 血 三 三 三 ώ 压 压 压 压 压 压Triglyceride is a metabolic syndrome. ϊ — - * Forget Dare sE: dx3ii Dang Ja > wheel braking benches not call back Yasushi continued # # Xu v ^ sqom ^ s benches drums manufactured by: z ____- ¾0 ^ - ^

⑤ 1357442 實施例5 針對高血壓及其他代謝症候群相關表現型之單套基因危險對比值 針對估計的Bin B之單套基因型C/ΑΑ/Τ的相對危險性或臨床 風險分別為1.5 (p=0.007)(高血壓)、1.5 (p=〇.〇〇8)(三酸甘油之偏 同)、1.8 (p=〇.〇〇〇l)(高血壓結合三酸甘油脂)及丨3 φ=〇 〇8)(代謝 症候群)。對於上述臨床結果,Bin D之單套基因型GTAG之危險 對比值分別為 1.5 (ρ=〇·〇2)、1.7 (p=〇.〇〇i)、1 9 (ρ<〇.〇〇〇1)及 1.2 (p 0.002) 〇 BinF的單套基因型危險對比值,並不與任何上述臨床 結果的風險增加有關。此外,我取Bins B及D的單套基因狀態, Γ人ί ΐ四種子群。具有任—於Bin B或Bin D風險單套基因^的 高的危麟比值。料 候群)(第二圖)。 ·則一者、、Ό D )及1.8 (針對代謝症 床結果相狀轉為6及5個具較高或較低,與臨 内含子區域4、5及6 同源個體)的脂蛋白脂分解酶基因之 基因結構。 & BlnsB至D) ’以確認並推斷的單套 27 1357442 【圖式簡單說明】 第一圖係闡明在本發明中研究的組成份,基因與 SNPs的相對位置。第一圖(a)顯示API基因圖。九個外顯 子,E1-E9,由標示E1-E9的垂直實柱表示。Bin A-F以實 盒顯示,下方並有字母A-F。SNPs 1-40位置(關於SNPs 之詳述見表三)顯示於LPL基因圖式上方平行線。第一圖 (b)顯示於Bins B、D及F中常見單套基因的序列。該百分 比指出於研究族群中各單套基因出現的百分比。 第二圖係顯示針對高血壓、三酸甘油脂偏高、高血壓 鲁 結合三酸甘油脂偏高(HTN-TG)和代謝症候群之Bin B和 Bin D單套基因型的危險對比值。舉例而言,最右邊的欄 位闡述Bin B之C/AA/T單套基因型針對代謝症候群之危 險對比值。當Bin D是GTAG時,針對個別單套基因型之 危險對比值是1.8。而當Bin D是GTCG時,危險對比值 質是0.9。5 1357442 Example 5 Single set of genetic risk comparison values for hypertension and other metabolic syndrome-related phenotypes The relative risk or clinical risk for a single set of genotypes C/ΑΑ/Τ for the estimated Bin B is 1.5 (p= 0.007) (hypertension), 1.5 (p=〇.〇〇8) (different triglyceride), 1.8 (p=〇.〇〇〇l) (hypertension combined with triglyceride) and 丨3 φ =〇〇8) (metabolic syndrome). For the above clinical results, the risk comparison values of Bin D's single genotype GTAG were 1.5 (ρ=〇·〇2), 1.7 (p=〇.〇〇i), and 1 9 (ρ<〇.〇〇〇) 1) and 1.2 (p 0.002) 〇 BinF's single genotype hazard comparison value is not associated with an increased risk of any of the above clinical outcomes. In addition, I took a single set of genetic status of Bins B and D, and Γ ί ΐ four seed groups. It has a high risk ratio of any single gene set in Bin B or Bin D risk. Material group) (second picture). · One, Ό D ) and 1.8 (for the case of a metabolic bed, the results are changed to 6 and 5 with higher or lower, homologous individuals with introns 4, 5 and 6 homologous individuals) The genetic structure of the lipolytic enzyme gene. & BlnsB to D) 'Single set for confirmation and inference 27 1357442 [Simplified illustration of the drawings] The first figure illustrates the relative positions of genes and SNPs in the components studied in the present invention. The first panel (a) shows the API gene map. Nine exons, E1-E9, are represented by vertical solid bars labeled E1-E9. Bin A-F is shown in a solid box with the letters A-F below. The SNPs 1-40 position (see Table 3 for a detailed description of SNPs) is shown in parallel lines above the LPL gene pattern. Figure 1 (b) shows the sequence of a single set of genes commonly found in Bins B, D and F. This percentage indicates the percentage of occurrence of each individual set of genes in the study population. The second panel shows the hazard comparison values for the single genotypes of Bin B and Bin D for hypertension, high triglyceride, high blood pressure, high triglyceride (HTN-TG) and metabolic syndrome. For example, the rightmost column describes the hazard comparison of Bin B's C/AA/T single genotype for metabolic syndrome. When Bin D is GTAG, the hazard comparison for individual genotypes is 1.8. When Bin D is GTCG, the hazard value is 0.9.

28 ⑤28 5

Claims (1)

1357442 申請專利範&年身修(更)正本 ^Β@Ί〇Ο^Ι2 月 19 曰 告'本 1. 一種用於預測病人之高血壓、三酸甘油脂偏^症候群 的風險之方法’其包括調查該名病人之脂蛋白脂分解酶(丄户幻美 因序列’且其中前述基因序列係選自下列標示了高血壓、三2 甘油脂偏高或是代謝症候群的風險之IPX單套基因所組 組: 、、’、拜 (a) 單套基因C/AA/T,其包含位於rs343的c ,位於rs252的 AA,及位於rs253的T ;以及 、 (b) 單套基因GTAG,其包含位於AF050163-2500的G,位於 rs269的T,位於rs270的A及位於rs271的g。 ; 2. ^專纖㈣1賴述之綠,其切料套基因為 3. ίτ^專職㈣1顿叙枝,其切料套基因為 第1細嫌,其切料套基因包含 1項^之方法’其中前述序列储由使用 交‘度嚴_件下進行特異性雜 11=利_第1項所述之方法,其倾述序列係藉由使用 人周邊血液所製備的DNA進行調查。 ’、曰 利範圍第1項所述之方法,射前述序列係藉由使用 8. 1 重用所製備❾眶、細胞或血清進行調查。、 的:壓、三酸甘油脂偏高或是代謝症候群 等基因椁t ^ 3 白脂分解酶_單套基因之同 成的群組早套係選自下列说單套基因所組 29 民國100年12月19日 (a) 早套基因C/AA/T ’其包含位於rs343的c,位於必2的 AA ’及位於rs253的T ;以及 (b) 單套基因GTAG ’其包含位於AF〇5〇163_25〇〇的〇,位於 rs269的T ’位於rs270的A及位於rs271的G ; ,中前述同祕因標記係藉由使用可__基因標記在高度 ,格條件下進行特異性雜交的寡聚核苷酸進行偵測,而前述同 等基因標記的出現,標示了高血壓、三酸甘油脂偏高或是代謝 症·候群的風險。 9.如申請專利範圍第8項所述之方法,其中前述同等基因標記係 藉由使用病人周邊血液所製備的DNA進行偵測。1357442 Patent application & annual body repair (more) original ^Β@Ί〇Ο^Ι2月19 Report 'This 1. A method for predicting the risk of hypertension and triglyceride deficiency syndrome in patients' This includes investigating the patient's lipoprotein lipolytic enzyme (the Seto Mirage Sequence) and the aforementioned gene sequence is selected from the following IPX single sets indicating the risk of hypertension, high triglyceride or metabolic syndrome. Gene group: , , ', (a) a single set of genes C / AA / T, which contains c located in rs343, AA in rs252, and T in rs253; and, (b) a single set of gene GTAG, It contains G located at AF050163-2500, T at rs269, A at rs270, and g at rs271. 2. ^Special fiber (4) 1 Lie's green, its cut set gene is 3. ίτ^ full-time (four) 1 nar The branch, the gene of the cutting set is the first one, and the method of cutting the gene contains one item of the method ^ wherein the aforementioned sequence is stored by using the 'degree of strictness' and the specific impurity 11=profit_the first item In the method described, the delineated sequence is investigated by using DNA prepared from human peripheral blood. ', 曰The method according to the above item 1, wherein the sequence is detected by using sputum, cells or serum prepared by using 8.1 reuse, or: high pressure of triglyceride or metabolic syndrome. ^ 3 White Lipase Degrading Enzymes - The set of the same set of genes is selected from the following set of genes. 29 The Republic of China December 19, 100 (a) Early set of genes C/AA/T 'includes c located in rs343, AA in 必2 and T in rs253; and (b) a single set of gene GTAG 'which contains 〇 located at AF〇5〇163_25〇〇, located at rs269 where T' is located at rs270 and located at In the G; of rs271, the above-mentioned homologous marker is detected by using an oligonucleotide which can specifically hybridize under the condition of height and lattice, and the appearance of the above-mentioned equivalent gene marker is indicated. High blood pressure, high triglyceride or risk of metabolic syndrome. 9. The method of claim 8, wherein the above-mentioned equivalent gene marker is carried out by using DNA prepared by peripheral blood of a patient. Detection.
TW94134166A 2005-10-26 2005-10-26 Risk prediction for hypertension, elevated plasma TWI357442B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW94134166A TWI357442B (en) 2005-10-26 2005-10-26 Risk prediction for hypertension, elevated plasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW94134166A TWI357442B (en) 2005-10-26 2005-10-26 Risk prediction for hypertension, elevated plasma

Publications (1)

Publication Number Publication Date
TWI357442B true TWI357442B (en) 2012-02-01

Family

ID=46728137

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94134166A TWI357442B (en) 2005-10-26 2005-10-26 Risk prediction for hypertension, elevated plasma

Country Status (1)

Country Link
TW (1) TWI357442B (en)

Similar Documents

Publication Publication Date Title
Chung et al. Exonic and intronic sequence variation in the human leptin receptor gene (LEPR)
Butler Pediatric hypertension: Genetics of hypertension• current status
Lyon et al. Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity
Alharbi et al. Insulin receptor substrate-1 (IRS-1) Gly927Arg: correlation with gestational diabetes mellitus in Saudi women
Andersen et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations
Girardelli et al. Genetic profile of patients with early onset inflammatory bowel disease
JP2008534009A (en) Multiple SNP for diagnosing colorectal cancer, microarray and kit including the same, and method for diagnosing colorectal cancer using the same
EP2256193A1 (en) Identification of hypertension susceptibility gene group
AU2016351311B9 (en) SCAP gene mutant and the application thereof
US7125667B2 (en) Polymorphic markers of the LSR gene
JP4140329B2 (en) Hypertension risk diagnosis method
Banno et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives
TWI357442B (en) Risk prediction for hypertension, elevated plasma
JP2008545387A (en) Method and configuration for cardiovascular disease diagnosis
JP4889258B2 (en) Method for determining resistance to the onset of bovine leukemia
US20080145855A1 (en) Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis
KR20220027690A (en) Method for providing information for metabolic syndrome disease and kits using the same
AU2004247896B2 (en) Mutations in the SLC40A1 gene associated to impaired iron homeostasis
US20050059079A1 (en) Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders
KR101046344B1 (en) Stroke Diagnosis Method Using SNP2 and Polymorphs as Biomarkers
US20060057615A1 (en) Risk prediction for hypertension, elevated plasma triglyceride and metabolic syndrome
JP5644009B2 (en) Determination method of inflammatory disease using single nucleotide polymorphism
US20060263817A1 (en) Genetic polymorphism associated with myocardial infarction and uses thereof
JP4649163B2 (en) Genetic predisposition test for bronchial asthma
KR101058583B1 (en) Multiple SNP for Cerebral Infarction, and Microarrays and Kits Comprising the Same

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees